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INTRODUCTION 
In the course of the battle between the living 
mammalian organism and the external environment, the animal 
body must make constant adjustments to meet stress situa-
tions and to maintain the homeostasi"s of the milieu 
i nterieur. The glands of internal secretion play an im-
portant role in these adjustments. Of the endocrine 
secretions, the hormones of the adrenal gland, both the 
cortex and the medulla are of paramount i mportance. 
In an evaluation of the metabolic alterations to 
stress situations,. it is necessary to realize that the 
endocrine glands are intricately regulated by a system of 
checks and balances. This system is most readily seen in 
the endocrine regulation of carbohydrate metabolism. It 
is obvious that the forces involved in maintaining a 
homeostatic level of carbohydrate metabolism can act i n 
only two dimensions, increase or decrease, and only \vhen 
these forces are at equilibrium, i.e., rate of production 
equals rate of destruction or i~nobilization, can a homeo-
static situation occur. It is interesting to note that 
the individual endocrine glands not only affect carbohy-
drate metabolism by the dir8ct action of their respective 
hormones, but in addition t hey exert an effect by influenc-
i ng ei ther directly or refl exly the activity of the other 
endocrine glands. Thus,_ the adrenal gland, the pituitary, 
and the thyroid act synergistically to increase the blood 
glucose while the islets of Langerhans act to decrease the 
blood glucose. It should be understood that the effect of 
artificial stimulation or injection of an individual hor-
mone will, in the intact organism, be governed by the exist-
ing endocrine balance in that organism at the time of 
stimulation. 
In the course of the past century, a great deal of 
emphasis has been placed upon the evaluation of the role of 
the adrenal gland in the control of body metabolism in the 
normal ·individual as well as in the individual during a 
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stress situation. This gland is interesting in that it is 
regarded anatomically as a s i ngle gross structure, yet physi-
ol ogically and histologically there are two units, each 
capable of functioning quite independently of the other and 
affecting each other only by way of another gland, the 
anterior pituitary, or by changes in tissue metabolism (103a). 
Therefore, when considering, for example, the effects in 
an intact animal of epinephrine administration of stimulation, 
it is necessary to remember that in addition to the actions 
of epinephrine, one is bound to reveal some of the effects 
of the adrenal cortical hormone, since the former will 
stimulate secretion of the latter by stimulating the anterior 
pituitary to secrete adrenocorticotropin. The beauty of the 
synergism of activity between the adrenal cortex and the 
adrenal medulla is readily exemplified in their effects on 
carbohydrate metabolism. 
Under conditions of general body stress, the 
adrenal medulla is stimulated, either directly or reflexly 
to secrete its hormone, epinephrine. It is the purpose of 
this study to evaluate the role of epinephrine and its 
action on carbohydrate metabolism. The initial body ad-
justment to stress sacrifices the homeostasis of carbo-
hydrate metabolism in order to meet the higher energy 
requirements of the organism. However, this interruption 
in the homeostasis is quite transient, and a new adjustment 
occurs at a higher level if stress is continued and its 
former level if it ceases. Ever since Blum 's experiment 
in 1901 (11) showing that epinephrine injected into a dog 
produced glycosuria, there has been an overwhelming number 
of reports in the literature which have offered theories 
and proofs of the mechanism of action of epinephrine in its 
effect on carbohydrate metabolism. 
It would be well, in this introduction, to con-
sider some of the fundamentals of carbohydrate metabolism 
and to define a few of the terms which will be used in 
the course of this study; for a misuse of terms is one of 
the reasons for the confusing results which are seen. 
The available evidence makes it rather cl ear that 
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in the postabsorptive mammalian individual the only source 
of blood glucose is the liver. The level of blood glucose 
is basically regulated much the same a s the level of water 
in a sink with a faucet and a sewer drain. One could cause 
the level of water to rise by four methods. First, the 
inflow from the faucet could be increased without increasing 
the outflow from the sewer drain; second, the outflow from 
the sewer drain could be decreased ·w·ithout increasing the 
rate of inflow from the faucet; third, both the inflow and 
the outflow could be increased \'lith the inflow increasing 
faster than the outflow; and finally the inflow could in-
crease and the outflow decrease in all proportions to each 
other. Exactly the opposite of the abov~ four methods 
would cause the level of the water to decrease and only 
when the inflow from the faucet is in dynamic equilibrium 
with the outflow from the sewer drain will the level of 
the water remain constant. The analogy to the level of 
blood sugar will be realized if one substitutes the liver 
supply of glucose for the faucet and the uptake of glucose 
by the tissues as the sewer drain {lOSa). 
The liver stores its glucose as glycogen. Under 
a given stimulus, this glycogen is hydrolyzed and phos-
phorylated forming a hexosemonophosphate ester, glucose-
1-phosphate which is isomerized to glucose-6-phosphate, the 
Cori ester. Under the action of a hexosephosphorylase, 
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_this ester is split into. phosphoric acid and glucose. It 
is generally considered that this reaction occurs within 
the liver cell, and the process is known as glycogenolysis. 
It is important to remember that this process is quite 
reversible, and as such it provides a means for glucose to 
enter the liver cell, and under the action of hexokinase 
be esterified with phosphate and undergo the transformation 
to glycogen. The liver glycogen can be formed, in addition, 
from carbohydrate metabolities, such as lactic acid, by 
an enzymatic conversion of two and three carbon fragments 
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to glycogen. This formation of glycogen from glucose and 
carbohydrate metabolities is known as glycogenesis. How-
ever~ liver glycogen can also be formed from non:...carbohydrate 
precursors, a process known as glyconeogenesis. The main 
precursors for this process are proteins, which in the course 
of their metabolism are broken down to two and three carbon 
fragm~nts. These fragments entering -the liver cell are ex-
posed to a number of enzyme systems, and are finally converted 
to glycogen (26, 43a, 6la, 108a). 
The muscle glycogen, which comprises the greatest 
part of the tissue glycogen is unable to form blood glucose. 
Like the liver glycogen, it is esterified with phosphate, 
then isomerized to form the Cori ester, the beginning of the 
process of glycolysis. However, follmving this, the ester 
undergoes a series of transformations, passing through a 
rmmber of acid forms, finally ending as pyruvic acid. 
This entire process is anaerobic, and if it continues i n 
an anaerobic state, lactic acid will be formed. In the 
presence of oxygen, the organic acid enters an oxidative 
cycle, whi ch is known as the Krebs' cycle, and finally is 
broken down to carbon dioxide and water . This entire 
process , the transformation of glycogen to its final end 
products, lactic acid, carbon dioxide, and water is an 
exothermic reaction, and is believed by most physiologists 
to provide the ultimate energy for muscular contraction 
{26 , 43a, 6la). This process of the degradation of glucose 
to carbon dioxide, water, and lactic acid , together with 
the ro cess of glyco genesis i n both liver and muscle, \ve 
shall define as glucose uti l ization. 
To complete the carbohydrate cycle, the lactic 
acid is carried by the blood stream to the liver where it 
is c onverted, as described above , t o .liver glycogen. In 
the mammalian organism, the muscle is unable to convert 
lactic a cid to muscle glycogen. How then does the muscle 
replenish its glyco gen? A process exactly the same as 
occurs in the liver also occurs in the muscle; i.e., muscle 
glucose and phosphoric acid are esterified under the action 
of hexokinase to form the Cori ester, glucose-6-phosphate. 
This phase of glucose metabolism, the removal of glucose 
from the interstitial fluids by the tissues, and its 
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phosphorylation, from now on will be referred to as the 
uptake of blood sugar to distinguish it from gl ucose uti-
lization, which refers to the combustion and catabolism 
of glucose as well as glycogen formation from hexosemono-
phosphate. The Cori . ester can undergo two main trans-
formations. It can either be isomerized to glucose-1-
phosphate , and then be converted to glycogen , or it can 
be broken down to the various acids finally forming carbon 
dioxide and water. In the literature, the amount of 
glucose uptake is called glucose utilization. If this \vere 
true, in isolated tissue studies, all of the glucose re-
moved from the medium should be accounted for in terms of 
glycogen synthesis and carbon dioxide and lactic acid 
formation. However, the results of previous studies (64, 
115 , 121) as .well as this study have been ~nable to support 
the validity of this hypothesis. Actually , it has been 
shown that it is possible for the isolated muscle to store 
hexosemonophosphate under certain conditions, i.e. , while 
under the influence of epinephrine (64 , 115 , 151). There-
fore, it is believed to be of paramount importance to 
separate the two phases , glucose uptake and glucose uti-
lization, in order to interpret the mechanism of epi-
nephrine activity in carbohydrate metabolism. 
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THE EFFECT OF ADRt;NERGIC BLOCKI NG DRUGS ON EPI NEPHRI Ni.:-
I NDUCED HYPERGLYCEMI A I N HABBITS 
INTRODUCTION 
A majority of the available adrenergic blocking 
drugs are lcno\vn to diminish or block many of the excitatory 
effects of epinephrine, although the positive chronotropic 
effect of epinephrine upon the myocardiwn is not knO\'ln to 
be blocked by any adrenergic blocking drugs. Since an 
excellent extensive revievv on the pharmacology of adrenergic 
blockade has been published by Nickerson ( 92), no attempt 
will be made to revie'"' this subject in this thesis. In 
view of the ability of the adrenergic blocking drugs to 
inhibit so many of the physiologic effects of epinephrine, 
it seems important to know the effects of these drugs on 
hyperglycemia produced by exogenous epinephril1e. Data 
concerning the effect of these drugs upon the metabolic 
effect of epinephrine are limited in quantity and scope. 
If adrenergic blocking drugs could be proved to block some 
specific phase in carbohydra·ce metabolism, they vvould be 
useful research tools for investigating the mechanism of 
epinephrine-induced hyperglycemia as well as other problems 
in carbohydrate metabolism. Consequently, the following 
experiments were made to determine whether or not some of 
the potent adrenergic blocking drugs recently synthesized 
are capable of blocking epinephrine-induced hyperglycemia. 
9. 
I'-'iETHODS 
Adrenergic blocking drugs were injected into male 
albino rabbits in order to deterrnine their influence on 
hyperglycemia induced by epinephrine injected 30 minutes 
after the test drug. All a gents were injected intravenously 
i n orde r to remove the influence of the rate of absorption . 
All experiments 111/ere performed on a series of 35 
rabbits which when not in use were k ept in individual vlire 
cages, and fed Purina Rabbit Pellets and cabbage. The 
animals were fasted for 18 hours p~ior to the test, and 
water was supplied ad libitum. They were acclimatized to 
the experimental procedures (sitting in rabbit boxes, in-
jection procedures, and withdrawal of blood) at least t wice 
before any data '>'~ere tabulated . No agent vlas t ested more 
t han once in the same rabbit, and the experiments were so 
designed that on any one day a number of compounds and 
saline controls were t e sted. The animals were placed in 
individual rabbit boxes which were uncovered except when 
inj ections or blood \vithdravvals were made. Blood samples 
1-vere tal en by cutting the ear vein and collecting a sar ple 
of freely flo1rfing blood . 
The procedure consisted of injecting the a gent to 
be tested over a one minute period. Thirty minutes later, 
a blood sample wc:ts t ak en and epinephrine ·was inj ected. 
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DosE-RESPONSE CURVE of epinephrine-induced hyperglycemia in rabbits. 
.Blood sampl es were collected at 5, 10 , 15, 20, and 40 mi nutes 
following the injection. The blood sugars were then deter-
mined by the Folin- Malmros micromethod. (41) . 
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A standard dose of 4 gamma/kg . of pure 1-epinephrine~:~ 
in a volume of 0.5 ml. was injected at a steady rate during 
3 0 seconds. This dose was selected on the basis of the dose-
response curve shown in Figure 1. Six doses of epinephrine 
were injected into a series of rabbits, and the blood sugar 
was measured at five mi nute intervals following the injection. 
A total of seven rabbits were tested with each dose. There 
vms no significant difference between 4, 8 , and 16 gamma/kg. 
while with 32 gamma the curve rose sharply, suggesting that 
the dosage level produced its effect by means of another mecha-
nism. This curve is in clos e agreement with the one described 
by Eadie (34). The dose of 4 gamma/kg. was reported (15) to 
be just within physiologic range. Furthermore, doses of a 
similar magnitude have been reported to induce a moderate 
hyperglycemia in rabbits (34), and cats (55). Although a 
saline injection did not have any 13ffect on the fasting blood 
sugar level over a period of 180 minutes, the injection of a 
standard dose of e pinephrine i nduced a prompt rise which 
reached its maximum at 15 minutes and returned to normal in 
40 minutes. The magnitude of the rise in blood sugar with 
this dose was surprisingly consistent, since it varied only 
from 27 to 40 mg./100 ml. of blood in 60 untreated rabbits. 
*Throughout this dissertation the dose of epinephrine is 
g iven in terms of pure 1-epinephrine base. 
TABLE 1. 
EFFECT OF ADRENERGIC BLOCKING DRUGS ON EPINEPHRINE-INDUCED 
HYPERGLYCEMIA 
com . ~ PREPARATIO ~ T F.STED 1 
1'- ·- . - - --- - - - ------
1 
1 Saline, control for d rugs I to 9 
I 
I I 
I 
I 
2 I 
3 
4 
I 
I 
Saline, control for d rugs IO , I I 
' (Sandoz-Dihydrocrgocorni nc 
DH0-18o) 
-2-ortho-E thy l-2-chloroethyl 
benzylphenoxyet 
HCI (Eli Lilly-o 
hylamine 
4679) 
1-Phenyl-2N-meth) 
aminocthylchlori 
Lilly- o8353) 
'!benzyl-
de HC! (Eli 
hyl-2 N -9- Fiuoreny i-N-et 
chlorethylamine 
Davis SY-21 ) 
HC! (Parke, 
thy l- 2-5 i 1-~aphthylmcthyle 
hromoethylamine 
(Parke, Davis SY 
HHr 
28) 
6 3-(N-Ethyi-N-2-ch !oro-ethyl) 
aminoethyl thian 
HCI (E li Lilly-
aphthene 
o8125) 
7 2-(2-Biphenylyloxy )-2'-chloro-
triethylamine HC 
Davis SY-8) 
I (Parke, 
oethyl) 8 N-Ethyi-N-(2-chlor 
benzhydrylamine 
(Parke, Davis SY 
HC! 
-2) 
loroethyl)-
anaphthene 
9 3(N-Methyi-N-2-ch 
aminomethyl thi 
HCI (Eli Lilly-o 8t24) 
zo r-Naphthylmethyle thyl-2 
ineHCI hydroxyethylam 
(Parke, Davis SY -73) 
!-benzyl-II r-Phenyi-2N-methy 
aminoethanol HC 
Lilly-o2074) 
I (Eli 
'DOSE I.V. 
mg/kg. 
I mi. 
I mi. 
0. I 
2 
2.5 
2 
2 
5 
5 
IO 
.'i 
4 
.'i 
MEAN I 
NO. OF LEVEL MEAN LEVEL MEAN 
RABBITS 30 MINUTES I 15 MINUTES RISE3 AFTER AFTER EPI,I 
DRUG 
mg% mg.% mg.% 
II I03:±:7 I40:±:II 37:±:4 
I4 101:±:3 132:±:4 31:±:4 
6 107:±:3 110:±:2 3:±:2 
. . 
6 II2:±:3 II4:±:5 3:±:3 
6 108:±:2 II0:±:3 2:±:2 
6 107:±:7 I2I±9 14:±:4 
6 II0:±:5 124:±:5 14:±:3 
I 
6 II2±6 126±8 14±4 
I 
I 
6 1I2±4 I 129±6 17:±:3 
4 108:±:6 145±9 37:±:5 
I I I 
4 II0:±:7 149±6 39±4 
5 102±3 I32±2 30±1 
! 
I 
i 
5 103:±:3 134:±:3 3I±4 
t Drugs I to 9 were tested in a group of 20 rabbits. Drugs 10 and I I, in 10 rabbits. 
I 
I 
! 
I 
I 
I I 
I 
' 
I 
I 
I 
I 
1 
I 
I 
I 
I 
%oF 
CONTROL 
RISE 
IOO 
roo 
8 
8 
5 
38 
38 
38 . 
46 
roo· 
105 
98 
100 
2 Epinephrine was injected i.v. in a dose of 4 }.Lg/kg. over 30 seconds 30 minutes after the i.v. 
administration of the blocking agent. 
3 Statistical comparison of group data for each of the compounds no. I to 7 with control data 
yields a P value < o.or. 
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RESULTS 
The effects of drugs on epinephrine-induced hyper-
glycemia are tabulated in Table l. The administration of 
an adrenergi c blocking drug did not chan8e the time of 
mcucimum rise in the hyperglycemic curve. Therefore , only 
the rise occurring at 15 minutes after the injection of 
e pinephrine is herein reported, although as mentioned above 
blood · samples at 5, 10, 15, 20, and 40 minutes \vere obtained . 
Each a gent was tested for its effect on the fasting blood 
sugar level in 3 rabbits and in no case was there any 
significant change over a period of 150 minutes. 
In most cases the dose of adrenergic blocking 
drug selected for use \vas sev(jral ·cirnes the dose required 
to reverse epinephrine-induced hypertension, since in these 
experiments we are probably dealing with only the excitatory 
phase of adre:nergic activiJcy, while in the blood pressure 
response both the excitatory and inhibitory phas es are 
present , and a slight 1c. eduction in the excitatory phase is 
exaggerated by the presence of the inhibitory phase. 
Di hydroergocornine. The phar macology of di hydro -
ergocorni ne ( DH0-180) hc'1. S been studied by Rothlin (102), 
v.rho found this agent to be a potent b lo cking agent as 
measured by the effect on hypertension i nduced with epi-
nephrine. In· his experiments t o test the effect of the drug 
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on epinephrine-induced hyperglycemia, both the DH0 -180 and 
epinephrine v1ere injected subcutaneously. His rmmlts show 
that hyperglycemia was diminished or blocked. In this 
study his experiment has been repeated, using the same dose 
of DH0-180, but injecting intravenously as described above. 
It is interesting to note that in each of the six: rabbits 
tested this agent produced az:1 effective blockade of the 
bl9od sugar rise in a dose which is smaller than the one 
required to consistently reverse epinephri ne hypertension. 
One wonders if t his means that the compound has a selective 
action on the liver cells. As shall be seen in a subsequent 
part of this study there is further evidence in support of 
the validity of this suggestion. 
The rema inder of the compounds tested belong to a 
series of 2-huloalkylamines. It ha s been found (94) that 
the ethyl hornologues of this series have a greater adrenergic 
blocking a ctivity than the methyl homologues, and if the 
halogen is replaced by an hydroxyl group the resulting com-
pound loses its blocking ability (78, 79 , 80 , 94). Several 
ethyl homologues have here been t es-ced for their effect on 
epinephrine hyperglycemia. 
2-0r'chobenzyl:phenoxyethyl. Compound 2( Table 1) 
\'lfas . previously reported ( 65 ) to be a potent adrenergic 
blocking drug. In the present experiments a dose somewhat 
larger than that required to reverse epinephrine hypertension 
.13 
in dogs produced a cornplete .blockade of induced hyperglycemia, 
in rabbits. 
1-Phenyl-2-N- IVIethylbenzyl. Preli minar y experiments 
( 20) have shown that compound 3 will reverse epinephrine 
hypertension in the dog in a dose of 2 mg. /kg. Follmving 
injection of 2.5 mg. /kg . of this agent , there was no change 
in the fasting blood sugar level in response to epinephrine. 
As vvill be shown i n the next series of experiments i n this 
study, this compound also reduced the hyperglycemia resulting 
from an infusion of epinephrine in dogs. VJhen the halogen 
of this compound was replaced by an hydroxyl group (Compound 
11) the resulting agent even in twice that dose did not 
affect the hyperglycemia in rabbits, indicat ing that the 
presence of the halogenated ethylamine gro up is required for 
the blockade of hyperglycemia as well as the pressor reoponse 
of epinephrine. 
9-Fluorenyl. Compound 4 has been found to be among 
t h e most potent of adrenergic blocking drugs ( 71 , 78 ). It is 
a s pecific a gent, antagonizing onl y the effects of epinephrine 
and some of its congeners . This compound in a dose of 2 mg ./kg. 
effe ctively reduced the induced hyperglycemia in rabbits and 
as we shall see l ater, in dogs , although a complete blockade 
did not occur. 
1-NaphthyJJ:nethyl. Previous reports have shcnm -r,hat 
Compound 5 i s a potent epinephrine antagonist (79 , 113), 
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although not s pecific in its adrenergic blocking act ivity, 
since it is a potent antihistamini c ( 78 , 79 , 113) . This 
compound in a dose of 2 mg . /kg . produced the same reduction 
in hyperglycemia as Compound 4. "\.'!}hen the halogen was re-
placed by an hydroxyl radical (Compound 10) the resulting 
agent lost all of its effect in antagonizing the epinephrine 
toxicity in mice (79 ) . This g ives further s upport to t he 
belief t hat the ability to i nhibit the hyperglycemic effect 
of epinephrine is r el ated to the ability to inhibit the 
other effects of e pinephrine . 
Dlethylthionaphthalene . Compound 6 is no t a s potent 
us the above compounds in its adr energic antagonism, a s 
measured by reversal of the pressor res onse to epinephrine 
(20). It re~uired a dose of 5 mg . /kg. to eff ect a reduct i on 
of t h e induced hyperglycemia equivalent to that obtained by 
Compounds 4 and 5. 
The methyl homolo gue of this compound ( Compound 9 ) 
was weak ly active in causing reversal of epinephrine hyper-
t ension (20), and had no effect on the induced hyperglycemia. 
Thus, it is again noted that an agent which loses its ad-
renergic blocking activity a lso loses its ability to reduce 
epinephri ne -induced hyperglycemia . 
2-Biphenylyloxy. It has been r eported that Com-
pound 7 is less potent than Compounds 2 to 5 when its 
blocking of adrenergic activity is measured (80). This 
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agent , like Compound 5, is . not only an adrenergic blocking 
drug, but a lso shows ant ihistaminic activity. Like Com-
pound 6 , a dose of 5 mg . / kg . only reduced the hyperglycemi a . 
Thus a gain there is evidence that adrenergic blocking drugs 
of lmv potency are not highly effective in diminishing 
epinephrine-induced hyperglycemia. 
Benzhydryl. Compound 8 has been described as 
being of the same order of adrenergic blocking potency as 
Dibenamine (78). Dibenrunine, itself, has been tested (93) 
(although the injections \vere made subcutaneously) , and 
found to be without effect in reducing induced hyperglycemia . 
However, further experiments (49 ) demonstrated that if the 
numbers of animals were increased, and a cross-over type of 
experiment vvas employed, a statistically significant decrease 
in the epinephrine-induced hyperglycemia could be demons~rated. 
The dose of test drug employed in those experiments was large. 
When Compound 8 was used in a dose of 10 mg./kg ., it failed 
to elicit a significant reduction in hyperglyc emia. 
'rhus, Compounds 2 to 5 ir-ih ich are the most potent 
members of the ethyl homologues of the 2-haloalkylamine 
series succeeded in blocking or markedly reducing the hyper-
glycemic response to 4 gamma/kg . of epinephrine. It required 
almost twice the dose of the less potent homolo gues (Com-
pounds 6 and 7 ) to effect an equivalent blockade, and the 
weakest member of the seri_es, (Compound 8) vvas \-vithout effect . 
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The methyl homologue (Compound 9) and the non-halo genated 
derivatives (Compounds 10 and 11) which are either devoid 
of the ability to reverse epinephrine hypertension or show 
a very weak adrenergic antagonism, were also 'Without effect 
in reducing epinephrine-hyperglycemia. 
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D.ISCUSSION 
As early as 1912, Miculicich (88) demonstrated 
that ergotoxin reduced the hyperglycemia and glycosuria due 
to subcutaneous injection of epinephrine in the rabbit. HO'\If-
ever, since that time, other adrenergic blocking drugs have 
been shown to be effective when used in the rabbit. 
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In 1929, Hanson (58) studied the effect of yohimbine 
on epinephrine-induced hype r glycemia. The rise in blood sugar 
was elicited by a subcutaneous injection of 0.1 mg./kg. in 
rabbits. This rise was completely suppressed by an intra-
venous injection of 1.5 mg. of yohimbine per kg. of body 
weight. vhereas the control blood sugar rose from 115 to 
315 mg . % in 1.5 hours after epinephrine injection, the rise 
in yohimbine treated rabbits was only from 115 to 135 mg. %. 
This slight rise in the yohimbine treated rabbit s could not 
be inhibited, even if the dose of yohimbine was increased to 
25 mg./kg . This study was a confirmation of the previous 
work of Nitzes cu (95). 
The influence of the benzodioxane derivatives vms 
tested by Blancher in 1934 (10). Working with rabbits, he 
injected epinephrine in a dose of 0.2 mg./kg. subcutaneously, 
and obtained exactly the same result as Hanson did using half 
of that dose, namely from 115 to 314 mg. %. This rise, how-
ever, was said to occur three hours after the injection 
rather than l. 5 hours reported by Hanson. It \vas shown that 
diethyl-amino-methyl-3-benzodioxane (883F) and piperido-
methyl-3-benzodioxane (933F) injected in doses of 50 mg./kg., 
subcutaneously, blocked this hyperglycemic response. 
Early experiments with Dibenamine, the first in 
the aryl-2-haloalkylarnine series, indicated that this agent 
\'las ineffective in diminishing the hyperglycemic effects 
of epinephrine. Nickerson and Goodman (93) in one of their 
first reports of the pharmacologic activity of this compound, 
reported their experiences in the attempt to block epinephrine-
induced hyperglycemia in rabbits. They injected their fasted 
rabbits subcutaneously with 0.2 mg./kg. of epinephrine, and 
followed the blood sugar rise periodically. They noted an 
increase of from 100 to 250 mg. % in 180 minutes. That this 
rise is less than that reported by previous workers may be 
accounted for oh the basis of more sensitive methods for 
blood sugar analysis. If the rabbits were pretreated with 50 
mg./kg. of Dibenamine given subcutaneously, the blood sugar 
rose from 125 to 240 mg. % in 40 minutes. It was claimed 
that there was no significant difference in the two curves 
except for the earlier peak following Dibenamine. This latter 
effect vms said to be due to a hastened absorption of the 
epinephrine under the influence of the block ing drug. How-
ever, the authors failed to take into account the f act that 
the hyperglycemic effect st~rted from a higher basal level, 
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1,25 mg. % a s opposed to 100 mg. %, and hence a reduction in 
the peak response of 25 mg. % could be shown. In addition, 
due to the hastened peak of response with a rather rapid 
return to normal, the area, i.e., the combination of magni-
tude and duration of hyperglycemia, was certainly curtailed 
following treatment with Dibenamine. 
That these small differences could be magnified 
into statistical significance was shown by Grant (49) who 
employed the cross-over type of experiment with 12 rabbits, 
and using the same dosage as Nickerson and Goodman, demon-
strated a statistically significant decrease in t he hyper-
g lycemia induced by epinephrine in those animals pretreated 
with Dibenamine. 
Hecht and Anderson (62) have found that Dibenami ne 
was ineffective in the blockade of epinephrine-induced 
hyperglycemia in man. 
In 1951 Chen and Clarke (lS) attempted to block 
e pinephr ine-induced hyperglycemia in rats using another 
of the ar yl-2-haloalkylamine series, N-(2-chloroethyl)-
N-ethyl -1-naphthaline methylamine. HCl (SY-14). They were 
unable to inhibit the effect of epinephrine given sub-
cutaneously in a dose of 0.5 mg./kg. with SY-14 given in 
doses of 6 and 12.5 mg./kg. However, 25 mg./kg. of SY-14 
given 1/2 hour before the epinephrine caused a decrease in 
the blood sugar while 50 mg./kg. blocked it completely. It 
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is noteworthy that if 25 mg./kg. of SY-14 were given 24 hours 
prior to the injection of epinephrine , there was a complete 
blockade of the hyperglycemia expected . 
Hecently, Harvey , \Vang, and Nickerson ( 61) have 
reported on the influence of a series of 15 compounds of this 
2-llaloalkylamine series on e pinephrine-induced hyperg lycemia . 
Their experiment::; differed from our own in that the blocking 
drug as well as the e pinephrine were injected subcutaneously . 
The blocking drug was allowed to act for 4 hours at which 
time e pinephrine i n a dose of 0 . 1 mg . /kg . was admi nistered . 
All 15 compounds tested manifested some degree of suppression 
of hyperglycemia . It wa::; no~ed that higher doses of block -
ing drug we re required to block the hyperglycemia effect 
than to block the blood pressure effect in many cases . Hmv-
ever, it should be borne in mind that the pressor effect 
of epinephrine is only an algebraic summation of pressor 
and depressor effects, and only a slight inhibition in the 
pressor effect would cause a change in the balance to allow 
the depressor effect to manifest itself in what appeared 
to be a partial or complete blockade . Hence in measuring 
pressor responses, one has the depressor effect of epi-
nephrine aiding the action of the blocking a gent , while in 
the hyperglycemic resuonse, the blockin g agent must act 
alone . These workt::Jrs did not find any corrt;llation between 
the abili ty t o su press the hyperglycemia and the abili ty 
2], 
to bloc __ pressor responses . Thu;:,, these authors f elt that 
the conc l usions reported f or this study ( 73u) ~overe un-
justified in view of their data and review of the lit erature . 
However , upon the exami nat i on of the data reported in their 
. paper, it appeared to this author that there v1as a rough 
C1l)proximati on of relative dose requi red for blocl ade · of 
hyperglycemia and blockade of pressor re s ponses , at least i n 
the rabbit . There are several except ions i n t hat some com-
pounds affecting the blood re sure r esponse do not · ffect 
the hyperglycemi and vice .versa . Hmvever, as wil be 
shm'Vn in the next series of experiments herei n reported , 
the in vi vo b l ockade of epi nephri ne-induced hyperglycemi· , 
at l east i n rabbits , i s b y no means limited tu the 
adrenergic blo cki g drugs . 1 s regards the review of the 
lit erature, Harvey et a l. have gl ecn1ed their eviden ce 
from vrork done i n several animal speci es . As will be 
pointed out in the next series of experi ments , it is ne c-
e ::>sary to confine one's sel f to a given species in speak-
i ng about thi s effect , s i n ce the response has some degree 
of species specificity . I t is still this author ' s con-
tent i on that there appears to be a rough correlation 
between the &o t ency of block in~ drug i n i ts effect on 
blood sugar i ncreabe and pres::>or e f fect due to epi nephr i ne . 
llis and Anderson (3 6) reported a sup~ress ion of 
e pi nephr i ne-induced hyperglycemi a i n the rat with Dibenarnine , 
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S:Y-2g, dihydroergotamine, and Priscoline. Priscoline had 
previously b0en reported to be ineffective in blocking the 
hyperglycemia (60, 66 ) but t.his was probably due to an in-
effective dosage level. The irnidazoline type of alk:yl;;unine, 
C-7337 (Regitine), has been reported to suppress epi nephrine-
i nduced hyperglycer:~ia in ma~ ( 63) • 
The natural and dihydrogenated ergot alkaloids have 
been studied more thoroughly than the other adrenergic block-
ing drugs in this response, probably becau;:;e of their earlier 
a ppearance in the laboratories. As was me ntioned e arlier 
in this discussion, Miculicich described this property of 
ergotoxin in 1912 (88 ) . Bar ger (7) in 193 8 has extensive ly 
revievied the older l iterature on the metabolic a ctions of 
the natura l ergot alkaloids , and the reader is referred to 
that reference for the earlier literature on t h e ;:;ubject. 
Recently , Rot hlin (101, 102) has shown that the di hydrogenated 
derivatives of the ergot alkaloids are increased in potency 
\·Jhen mea:.:>ured against the hyperglycemic actions of epinephrine . 
However, this potency ,,v-as not increased quite as much as 
against the pressor effects of epi nephrine. However , the 
doses required to block the hyperglycemia were much smaller 
than those necessary to inhibit the hypertensive a ction of 
epinephrine. Dihydroergotamine (112), and dihydroergokryptine 
(42) have also been shown to be active in preventing 
epinephrine-induced hyperglycemia in man. In addition , it 
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pas been shown that ergonovine ( 60 ), with no knovm adrenerg ic 
blocking activity , in large doses blocked hyperglycemia in-
duced by epinephrine. It is this a uthor's b elief that this 
is due to some i ndirect effect since it \'Ifi ll be shown in 
the next section t here are other agents v-ri thout adrenergic 
blocking activity \vhich will inhibit the hyperglycemia. 
A discussion of the possible mechanisms of action 
of some of these agents will be found in the last oection 
of this thesis. 
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3UflTI·lARY 
: number of adrenergic blocking drugs were tes"Ged 
i n rabbits for their effect or1 ep i nephri ue-induced hyper-
g l ycemia . \iith the exceptio11 of dihydroer gocorni ne, all 
the agents tested be longed to a series of 2-haloalkylamines . 
It is suggested that the effectiveness of 2-haloalkyl amines 
i n diminishing or blocking epinephrine-induced hyperglycemia 
i n rabbit s is roughly re l ated to their potenty as mec_i.sured 
by antagonism of ot her ef fe cts of epinephrine . The basis 
for this suggest i on is that the most ?Otent drugs bl ock or 
d i minish the blood sugar rise i n a dose of 2 mr; . /kg . , while 
the l es s potent homologues re qu i re a dose of 5 mg . /kg . to 
obtain the same effect . The least potent of these agents 
did not reduce the hyperglycemia even i n a dose of 10 mg . /kg . 
In a ddit i on , the methyl homologue of one of, these adrenergic 
blocking drugs knO\vn to have a markedly reduced epinephrine 
aHtagonism d i d not have any effect on hyperglycemi a . Li ke-
wise , when the halogen is replaced by an hydroxyl group , 
and the resulting agent l oses its epinephrine reversa l 
act i on , it a lso loses i ts ability to .block epinephrine-
i nduced hyperglycemiu . A review of tl~ lit erature t ogether 
with the data obtai ned seems to indicate that it i s a 
general property of the adrenergi c blocking drugs to in-
hib it the hyperglycemic response to epinephrine in the 
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rabbit . However , this effect may have some species speci -
f icity. In addition, some ot her agents without adrenergic 
blocking act ivity may el i cit this response . 
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THE EFFECT OF CERTAI N ANTIHI STATviiNES ON EPINEPHRil'I~-INDUCED 
HYPEJ:lGLYCEI-liA I ;J TH1~ HABBIT. ALSO , TH E I NFLUENCE OF 0EVBRAL 
ANTIHISTAtl.liNES AND ADRENERGIC BLOCKING DRUGS ON ~ PINEPHRIN£­
I NDUCED HYPERGLYCEMIA AND LACTICACIDEIVIIA IN THE DOG . 
INTRODUCTION 
1- ttent i on has been drawn previousl y to the fa c t 
that several synthetic drugs posses::, i ng ant ihistamirlic 
properties were a l so capable of di minishing or blocking 
some excitatory effects of epinephri ne (76 , 77) . The aost 
striking exampl e was the dis covery t hi.1t l-naphthylmethyl-
2-bromoethy l ami ne HBr ( SY-28) -w-as a potent adrenergic 
blocki ng drug of the 2- ha l oal kyl ami ne type , a nd , in ad-
di~cion, thi s drug exerted a strong antihi stc.:t.inini c act i on . 
Thus a single compound pharmacologi cal ly antagoni zes the 
effects of epL1ephrine and hi s t ami ne , s ub st illl ces which a re 
in themselves antagonists in many r espects . Nevertheless , 
t h e r;1a jority of ant i h i stami ne s are f airly speci f ic with 
r espect to h i s t amine blockade , a l though many of them are 
known to increase the pressor responses to epi nephrine i n 
anesthet i zed dogs (77) . As i ndicated pr evi o us l y (76, 77) , 
the abil i ty of ant i h i stami nes e i ther to i nc rease or de-
crease certai n effects of epinephri ne suggests that there 
raay be some ~ imilarity i n the ult i mate s i te or me chanism 
of a ct i on of h i stami ne and ep i nephri ne . The evidence cited 
certainl y ::;uggests that the c:mt i histami nes v1hich heretofore 
have been regarded as rat her spe ci f i c might influence some 
effects of ep i nephri ne other than those reveal ed i n previ ous 
studi es. 
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Accordingly, s~veral of the available antihistamines 
have been te::;ted for their ability to influence epinephrine-
induced hyperglycemia in ·rabbits. In addi tion , the question 
of species specificity as \'Jell as the ability of agents 
without blocking a ctivity to influence this response has 
been examined. 
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Rabbits. Iviale albino rabbits maintained on a 
diet of rabbit pellets and greens as previously described 
were fasted for 18 hours prior to an experiment. Fo llowing 
the withdrawal of fasting blood samples from the marginal 
ear vein, the agent to be tested was administered intra-
venously into the other ear i n a volume of 1.0 ml./kg. 
The injection was made slowly at the rate of 4 ml. in 2 to 
3 minutes. Either 15 or 30 minutes later another blood 
sample was '1'/ithdrawn, and pure 1-epinephrine base in a dose 
of 4.0 gamma/kg. in a volume of 0.1 ml./kg. was injected 
intravenously during a period of 30 seconds. The reasons 
for this choice of dosage of epinephrine were mentioried in 
a previous portion of this treatise. Blood samples were 
obtained from the marginal ear vein at 10, 15, 20, and 30 
minutes following the epinephrine injection. The experi-
ments were arranged so that no rabbit was tested more than 
once ~ovith a given drug, and at least t~ovo agents with a 
saline control were tested on any given day. 
Dogs . Six female mongrel dogs weighing 13-17 
kg . were trained to stand in dog stocks and to submit to 
experimental procedure without excitement. These animals 
were fasted for 24 hours before an experiment. After with-
drawal of a fastin g blood _sample from the vein of a forelimb, 
the agent to be tested was injected intravenously in a 
concentration of 10 mg./ml. over a 3 minute period. One 
half hour later another blood sample vms withdrawn, and a 
solution prepared from pure 1-epinephrine base ~vas infused 
at the rate of 1 garnma/kg./rninute for 15 minutes. Following 
this infusion, samples of venous blood were obtained at 0, 
10, 20, 30, 45, 60, 75, and 105 minu"Les. In another series 
following injection of 4 gamma/kg. of epinephrine during a 
30 second period, venous blood samples were obtained at 0, 
5, 10, 15, 20, 40, and 60 minutes. 
All blood samples of both rabbits and dogs Nere 
tested for their blood sugar content by the micromethod 
of Falin and Malmros (41). The blood samples were tested 
for their lactic acid content by the method of Barker and 
Summerson ( 8) • 
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TABLE 2. 
Effect of antih1:stam:in-ics on cp1:ncphrinc-inrluccrl hypcrglyccm:ia 
--------------------------------------------------------------------
11RPC TF.STED* 
DOSE 
liSEn 
I. V. 
MEAN' LEVEL 
.l!l' AFTER 
TREATMF.:\'T 
"EAN LF.VF.L I I "' 
lS' A FTF.R \t :1\ :'\ JOSE t o OF 
El'l. CONTROLf 
mgm. j kgm . 
, .. 
m~:m . . o 
± S.IJ . 
111J.:IU. f·; 
± s.n. 
m~;m. r·; 
± S.IJ . 
_s_ai_i•_•e __ <_l·l_rahb~~--------------- 1 ml. 101 ± :~ 132 ± -1 :~ 1 ± 2 I 100 
!_!) ___ I~ 15 --±--2 : ~ 17 ~---; ~~----;-,-;;-N , :\' -Dimet hy 1- i\ 1 - (cv- Jl.ni d.l'l )- :\ 1 - (cv-
t hionyl) et hylene diamine · IICI 
(Histadyl) 
' :~ I IOTJ ± n 
1
110 ± I a, ~ ± a I 10 I I I 02 ± ~ 1 I() ± -I I 17 ± I 55 
II~;--~ 12 --±- 5 ~~-±---; ~-;-± ~- ---~-N 1-Pyridyl-:\' 1-5-C'hlorot lwnyl-X -di-methyleth~· I e ned iamine citrate (Chlorothen ) 1 02 ± 2 125 ± 5 2:3 ± 4 7 4 I 
I\ 1-p-:\let hoxybC'nz~· I-N 1 ,:\ 1-dimet h~· l - a- ~ 
pyridylethylenedia mine malC'ate (:\eo-
antergan) 
N .~-Dimethyl-'i\ 1 -benzyl-:\' 1 - (a-pyrid~· J ) - 3 
et hylenediamine · HCI (Py ribe nzamine ) 
1 06 ± 5 111 ± !) 5 ± 2 16 
103 ± 5 106 ± 4 3 ± 3 10 
N 1-,S-Dimethylaminopropylthiodiphen~·J- 3 101 ± 3 107 ± 4 5 ± 5 16 
amine· HCI (Phenerg:m2_ ______ ___ _____ _I ___________________ __ 
1- (p-Chlorophen~· l )- 1- (2 - p~Tid~·l) :J :\ ·i- 3 103 ± 5 114 ± !) !) ± -1 2() 
dimethylpropyi:Jmine maleate (ChiOI'- 103 ± 3 1 127 ± 4 2-1 ± 2 77 
trimeton) 
1- ( 10-Acrid~· l ) -2-dime~~- ;~ninoet~:;- _ 3 ___ ~06_±_S ~ 09-±-~ ~-;-~ -
HCI (Lill y 017!)8) · I 
--------- ------ ------- ___ __ I ____ _ -----·----
1-Dimethylamino-2- (21-benzyl--1'-clt lor- 3 lOS ± -1 122 ± 5 16 ± 2 I 52 
phenoxy) ethane·HCI (Lilly 01780) I I 
-------------- - --- ----- - - ------------·------'-----
N , X -Dimet hyl-:\' 1 -phen~· J<\ 1 -(2-thie nyl- 5 1 107 ± 5 12-1 ± 61 18 ± 2 ! 58 
methyl) ethy lenedi am ine· Il CI (Diatrin ) 1 I I 
·,s-Dimeth~rlaminoet h}~~e~zhydr~~---- ~--;---- 1~ 0~--:.::-5 ~ 31-±-~~ 27 ±-;- :l-~;-
ether·HCI (Ben:ulryl ) _ 
2-l\llethyl-!)-phen }~ 2 ,;,-:;-,!)_tetrahyJro-1~ ~--5---- ~ 0-l--±--; 1~31-±-~ 1 27 ±- 2 ~-87 
pyridindene tartrate (Thephorin ) \ 
N ,X-Dime~yl-::\ 1 - ( p:!et~ox~· l>e n7.~)--- ·--;--- ~06 ±-~ ~ 28-:---; ; 22~-:;- -71-
. I\ 1 -(2-p_vrimicl~· l ) ethylenediamine· I I 
HCI (:\'eohetramine) I 1 
2[:(2-Dimeth~· laminocthox~·)-a-:ne~yl=- 1-;---- 11~03_±_:; 11~26_±_--; : -23 __ ± __ 2 - 7-J-henzyl~>yridine ~IcC'in~~~ecapryr~ _________________________ __ 
N -::\Iethyl-::\1 1 - ( 4-chlorohenz h~·clry I) 
piperazine·2 HCI (Pera zil ) 
j . 3 I n- 3 n t 1 102 ± · I 1~, ± ~ ... ± 
: I 
77 
Epinephrine (-1.0 mierogm. / kgm .) 11·as injected l.V. 30 minutes after the te,; i drug or 
£aline was inj ected. 
*Each drug and ea<'h dose were tested in 5 rabbit s from a pool of 15 rabbit s . 
t The "p" value of all agents ,,·hen compared 11·ith sa line l>y group means eqt;ab < 0.01. 
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.RESULTS 
A. Hyperglycemia in Rabbits: 
The effects of antihistaminic a gents on epi-
nephrine-induced hyperglycemia in rabbits are listed in 
Table 2. It vms found that when antihistamines were in-
jected intravenously and slowly, as they were in this 
series, they did not produce any rise in the fasting blood 
sugar level. Thenylpyramine (Histadyl), N- pyridyl- N'-5-
chlorotnenyl-N-dimethylethylenediamine citrate (Chlorothen), 
Pyranisamine (Neoantergan) , Tripelenamine (Pyribenzarnine), 
N'-2-dimethylruninopropyl thiodiphenylamine. HCl (Phenergan}, 
Chlorprophenpyridmnine (Chlortrimeton) and 1-(10-acridyl)-
2-dimethylaminoethane . HCl (Lilly 01798), have been de -
scribed as being among the most potent antihistaminics (20, 
75, 76, 122) . 
These were found to be the most effective in 
diminishing epinephrine-hyperglycemia in rabbits. Such 
activity cannot be due solely to the ethylenediamine 
structure contained in the five compounds listed in Table 
2, since this structure is absent in the two active com-
pounds, Chlortrimeton and Lilly 01798. Furthermore, 
aminophylline proved ineffective even though the amount 
i njected represents at least t1-vice as much ethylenediamine 
as contained in an effective dose of antihistamines of the 
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TABLE 3. 
Effect of various agents on epinephrine-induced hyperglycemia in mbbits 
MAXIMU~1 RISE 15 "p" VALUE OF 
NO . DRUG TESTED\ DOSE I.V. DRUG VS. ii<HN . AFTER EPI. CONTROL2 
mgm./ kgm . mgm.% ±S.D. 
Saline-14 rabbits (for '# 1-3) 1 ml. 31 ± 2 
Saline-9 rabbits (for '# 4-8) 1 ml. 31 ± 3 
1 . Aminophylline 10 30 ± 1 >0.05 
2 Sodium pentobarbital (Nembutal) 30 30 ± 1 >0.05 
3 Procaine H Cl 5 31 ± 2 >0.05 
4 Cocaine HCl 2 32 ± 2 >0.05 
5 Atropine Sulfate "3 31 ± 4 >0.05 
6 Pitressin 0.2 u. 4 ± 3 <0.01 
7 Pitocin 0.2 u 20 ± 4 <0.01 
8 Ephedrine Sulfate 3 6 ± 6 I <0.01 
Epinephrine (4.0 microgm. / kgm.) was injected I.V. either 30 min. ( '# 1-3) or 15 min. 
( '# 4-8) after the test drug or saline was injected. 
1 Each drug was tested in 5 rabbits; number 1-3 from a pool of 15 rabbits; number 4-8 
from pool of 12 rabbits. 
-
2 
'P' value determined by comparison of group means. 
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ethylenediamine type. In .addition, appreciable doses of 
lVIethapheneline (Diatrin), and Thonzylamine (Neohetramine) 
which do contain the ethylenediamine structure did not 
markedly inhibit the epinephrine-induced hyperglycemia. 
The last seven compounds listed in Table 2 are not highly 
potent antagonists of hist~1ine. These compounds only 
slightly reduced the hyperglycemia induced by epinephrine, 
even though the dosage employed was usually 5.0 mg./kg. 
It is suggested, in view of these data, that the ability 
.of the antihistarninic drugs to block epinephrine-hyper-
glycemia in rabbits is related to the potency of these 
agents as measured by the antagonism of the effects of 
histamine on the bronchioles and on the ileum of guinea 
pigs. 
Since the antihistamines have been regarded as 
fairly specific agents , it was of interest to determine 
whether any agents in addition to adrenergic blocking 
drugs and antihistamines \I'Tould produce an inhibition of 
epinephrine- hyperglycemia. The agents tested and the 
results are listed in Table 3. Since neither cocaine nor 
procaine altered the blood sugar rise, it is unlikely 
that the effectiveness of the synthetic antihistamines is 
related to their local anesthetic properties. In addition, 
the fact that atropine was ineffective indicates that the 
atropine- like activity of some of these agents is not 
3.3 
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TABLE 4. 
The effect of anf'iJu:sla11dne and adrcncryic hlocb "nu druys on epinephrine -induced 
hypery lycc mia and laclicacidellli(/. h 1, dvus 
Treatmentn 
Epinephrine in-
fusion Control 
Histadyl 1.5 
mgm. / kgm. 
Chlortrimeton 
3 mgm. / kgm . 
Chlorothen 
5 mgm. / kgm. 
BLOOD GLUCOSE BLOOD LA CT IC ACID 
Mea n 
Max . rise 
mgm. % 
±S.D. 
ph 
Mean 
area" of 
hypergly-
cemia 
mgm.min. 
±S.D. 
ph 
.1\lcan 
max. rise 
rngm . % 
±S. D. 
p h 
I :\lea n 
II a T('ll c· Of I la c tie-
l 
a cidem!a 
mgm. mm. 
± S. D. 
a) Epine phrin P. infus io n of micrngn L/ kgnL / nlin . fo r 15 min . 
34. i ± 1.3 1600 ± .t32 2i .2±2. 2 1086 ± 3i6 
45 . 3 ± 3. 1 < 0 . 01 190-1 ± 501 0 . 2 < p < 0 .3 2iU ± 2 .3 0 .02< p < 0 . 05 1029 ± 139 
44.0± 1.5 <0 . 01 1596 ± 21'<2 > 0 . 5 1'<.2 ± l. li 
28.2 ± 1.1 <0.01 936 ± 2.t2 O.OL < p < 0 .02 ::! S. 5 ± 2 .1 0 . I 
> 0. 5 1092 ± 158 
< p < O. 2 11 92 ± 20.t 
p b 
> 0 . 5 
> 0 .5 
> 0 . 5 
N -9- F luorenyl-n-
ethyl-2 chloro-
ethylamine 
i . 3 ± ::!.3 < 0 . 01 146 ± fj(j 
I 
< 0.01 :n. 5 ± 2.5 < 0 .0 1 lli5 ± 229 O.Ol < p<O . OZ 
HCl. (Parke, 
Davis SY-21 ) 
2 mgm. / kgm . 
l -Phenyl-2N- 14. i ± 1. 4 < 0 . 01 359 ±!.tO < 0.0 1 ;2\1 . 5 ± 2.ti < 0 .01 10\) 4 ± 138 
methyl-benz yl-
aminoethyl 
chloride HCl. 
(Lilly 08353 ) 
2 mgm ./ kgm. 
Dihydroergocorn- 34 . 6 ± 2.6 > 0 . 5 !Otil ± 6:i.5 0 .3 < p < O. ·I 
ined (Sa ndoz 
2 ~. 2 _± 1. \l 0.2 < p < O. :l 
1
122 i ± 102 
DH0-180) 0.05 
-0 . 1mgm./ 
kgm . 
I 
I 
---------------------------- ----
b ) I<:pine phrine injecti on of 4.0 microgn• . / lq~m·. n Yn a :30-:-<ecnnd perio d 
> 0. 5 
> 0 . 5 
---------
26 .0± 3. 5 1 604 ± 150 20.3 ± I. i Epinephrine in-
jection (C o n -
trol ) 
C hlorothe n 5 
111gm ./ kgm. 
15 . 5 ± 2 . -1 <O .OI .J G6 ± ~s 0 . 1 < p < 0 . 2 121 . :l ± I . I 
I 
a Drugs injecte d 30 min . b efo re l' pine phrinc adruini :-< tratitlll. 
"Determine d b y 'paired da t a · a nHlys is with C'ontro ls. 
" D e termine d b y 'Trapezoid HuiC' ' . 
326 ± ll.t 
> 0. 5 a:11 ± !1 5 < 0 5 
° Combint>d res ults of 2 d ogs with 0.05 mgm. / kgm : and 3 do~o:s wit II 0 .1 1111-!111. k g11 1. ~ in cc rl'" l " ' ll "~'" a r\' of "H illt ' 
JJIHgniturlt> . R t> m a inder of dnJgs t estt>d on 6 d ogs C'a e h . 
responsible for their ac.tivity. It .is noteworthy that 
Pitressin, Pitocin and ephedrine were all effective in 
reducing the hyperglycemia. These three agents are all 
known to produce vasoconstriction and other circulatory 
changes. One wonders if these agents could be interfering 
with the activity of epinephrine by a redistribution of 
blood, and a resulting interference with the distribution 
to all parts of the body of any hyperglycemia produced. 
B. Hyperglycemia and Lacticacidemia in Dogs. 
It was important to know whether there were any 
species specificity with regard to the inhibition of · 
epinephrine-hyperglycemia. To this end, epinephrine was 
infused into trained dogs at a physiologic rate (15), and 
the blood sugar was measured at intervals in cont rol and 
drug-treated animals. It was also of interest to know 
whether the lacticacidemia knmvn to occur after epinephrine 
injection would be affected, thereby reflecting an action 
in muscle as well as liver glycogen. The data are tabulated 
i n Table 4. Each dog served as its own control. The peaks 
of the hyperglycemia and l a cticacidemia have been tabulated 
in addition to t.he respective areas under the curves from 
onset to completion. It is suggested that the maximum 
rise most clearly demonstrates the effect of epinephrine 
itself, since t he duration (reflected by the area ) may be 
influenced by a number of other factors such as insulin 
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and adrenocortical hormones. 
The peak response occurred from ten to twenty 
minutes after the end of the epinephrine infusion, and in 
control animals reached a height of about 35 mg. ih . Interest-
ingly, Histadyl and Chlortrimeton, which were among the most 
potent of the antihistaminics tested in rabbits, did not 
decrease the hyperglycemia in dogs; on the contrary, they 
potentiated the maximum rise, a lthough they did not alter 
the fasting blood sugar level. However, the total area 
of the hyperglycemic curve was not differen1; from the 
controls. Histadyl produced a significant inc;rease in the 
peak level of lacticacidemia without altering the total 
area of response, while Chlortrimeton produced rio alteration 
in the lactic acid rise following epinephrine. It will be 
noted that while the dose of Histadyl used in rabbits to 
produce complete blockade of the hyperglycemic effect of 
e pinephrine \vas 3.0 mg . /kg ., the dogs rece ived only 1. 5 
mg ./kg. Doses higher than this were found to be convulsive 
to dogs, and 1.5 mg. /kg. was found to be approximately the 
maximum tolerated dose. 
Chlorothen \vas well tolerated by the dogs, and 
a dose of 5.0 mg./kg. si gnificantly decreased the hyper-
glycemia both in height and duration wi thouti altering the 
lacticacidemia or the fasting blood sugar. 
It will be noted in the experiment on dogs, that 
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the experimental design was altered from that of the rabbit 
experiments in that the epinephrine was infused instead of 
injected. It vvas important to determine if this change in 
experimental design was responsible for the results which 
differed from those obtained with rabbits • . Accordingly, 
epinephrine was injected in~ravenously in a dose of 4~0 
gaTI'J!Tia/kg . over a 30 second period into dogs which had been 
injected intravenously \vith 5.0 mg./kg. of Chlorothen 30 
minutes earlier. The results as shown in the bottom of 
Table 4 demonstrate that Chlorbthen reduced the hyper-
glycemic effects of epinephrine injected in this manner 
more than \'Then epinephrine was infused. Interestingly, 
the area of hyperglycemia follo~nng the infusion of epi-
nephrine was diminished by Chlorothen, while the area of 
the hyperglycemia folloV'Iing the injection of epinephrine 
vws unaffected . The findings of Sus ina and Unna ( 114) , 
using an epinephrine injection of 5.0 gamma/kg. were 
simila r t o those reported herein. They found that diphen-
hydramine (Benadryl) and Chlortrimeton potentiated the 
hyperglycemia while Thephorin diminished it. Their 
measurements of hyperglycemia were exclusively by areas. 
It is fe lt that these experiments vvi th varied 
methods of administration of epinephrine add weight to the 
suggestion that the influence of the antihistamines on the 
response measured is possibly a hemodynamic one. 
3.6 
In view of the . negative results vdth the anti-
histaminics in their ability to block the effects of 
epinephrine in inducing hyperglycemia in dogs, a series 
of experiments were included using the adrenergi c blocking 
drugs, N-9 - fluorenyl - N- ethyl-2 - chloroethylamine . HCl (SY-21) 
and 1-phenyl-2-N- methyl- benzylwninoethylchloride . HCl 
(Lilly 08353) to see if a marked inhibition of epinephrine-
induced hyperglycemia was limited to rabbits. These agents 
were inj ected into dogs in a dose of 2 mg./kg., and the 
hyperglycemia following the infusion of epinephrine was 
markedly reduced from the control value both in magnitude 
and duration. Both of these agents caused an increase 
over the control values in the lactic acid rise, but only 
SY-21 produced an increase in the total area of lactica-
cidemia. 
The adrenergic blocking drug, dihydroergocornine 
(DH0 - 180) wa~ injected intravenously into dogs, but the 
dose used in rabbits (0 . 1 mg./kg.) was found to be emetic 
in dogs. It did not produce any change in hyperglycemia 
or la.cticacidemia in the 3 dogs in which it ~<vas tested·. 
The dose v-ras reduced to 0.05 mg./kg. and retching without 
vomiting was noted in 2 dogs tested . Again there was no 
al~eration in t he blood sugar or lactic acid changes pro -
duced by epinephrine infusion. 
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DISCUSSION 
The reduction of an excitatory effect of epi-
nephrine by compounds possess ing antihistamine properties 
ha s been previously reported . 2-Isopropyl-5-methylphenoxy-
ethyl diethylamine ( 929F) ( 13) , 1-na~Jhthylmethyl-ethyl-2-
bromoethylamine (SY- 28) (79) , and N-2 (2-biphenylyloxy)-2 '-
chlorotri ethylwni ne (SY-8) (80), have been shown to inhibit 
the pressor r esponse to injected epinephrine in dogs . On 
the other hand , several of the available antihistami nes 
have been shown to potentiate t he effect of epinephrine 
in dogs (77) . Furthermore , evidence is avai l able which 
indic<.:ttes that at least one of ·the antihistamines, Benadryl, 
i s capable of reversing epinephrine reversal (19) . The 
mechc..1nism of action of the · antihistamines in their diverse 
effect on the a ction of epinephrine is unknown . It has 
led to the suggestion that "che ultimate site or mechanism 
of action of epinephrine and histamine on certain tissues 
is similar (76 ). It is possible that the antihistamini c 
agents are effective, therefore, by blocking such a comraon 
site of a ction at the liver . It is more likely , however , 
that the antihist<:1mines act in some non- s pecific manner, 
such as circul atory changes in which carbohydrate metabolism 
may be only inci dent ally involved. The fi nd i ng that agents 
such us Pitocin , Pitressin , and ephedr ine, which i nduce 
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c.irculatory changes, also ;inhibited epinephrine-induced 
hyperglycemia in the rabbit, makes this hypothesis likely. 
'rhe failure of some of the potent antihistamines 
to b lock the hyperglycemia in dogs may reveal a species 
difference, which, as was pointed out in the previous 
section, proved to be an important consideration in evalu-
ating the effects of drugs on epinephrine~induced hyper-
glycemia. With at least two antihistaminic agents, Histadyl 
and Chlortrimeton, there was, in the dog, a potentiation 
of the hyperglycemia similar to the potentiation of the 
pressor response in this animal. 
To this author's knowledge, there has been only 
one other attempt to study the effects of the antihistamines 
on epinephrine-induced hyperglycemia in the dog. Susina 
and Unna, in 1951 ( 114), working with dogs and using tech-
niques very similar to the ones used in this investigation, 
found a potentiation with Benadryl and Chlortrimeton. 
They found, hm'lever, that Thephorin produced a reduction in 
the hyperg~ycemia. The only drug that we used in common 
was Chlortrimeton which ~..,e also found potentiated the hyper-
glycemia induced by epinephrine. It will be noted, that 
Chlorothen was the only one of the drugs we tested that 
reduced the hyperglycemic response to infused epinephrine 
significantly both in magnitude and in area. In response 
to injected epinephrine , the dogs pretreated with Chlorothen 
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did not show a signific9-ntly lm:1er area of hyperglycemia 
but did not show any evidence of a potentiation . One a lso 
wonders if the failure of the antihistamines to have any 
effect might not be due to a dosage effect. It will be 
noted that the dose of Hi stadyl could not be raised above 
the 1.5 mg ./kg., while the Chlorothen was injected in a 
dose of 5 mg./kg. 
Chen and Clarke (17) studied the effect of Benadryl 
on epinephrine-induced hyperglycemia in rabbits. :2:pinephrine 
\"la s injected in a dose of 0.1 to 0.2 mg./kg. and Benadryl 
in a dose of 20 mg ./kg. Both drugs were injected subcu-
taneously. It was found tha t both agents were hyperglycemic 
and that their effects were additive. The effect of the 
Benadryl could be removed 1ri th pentobarbital anesthesia. 
Although Benadryl g iven intravenously, as we used it, did 
not cause a significant hyperglycemia, our results are 
essentially the same as those reported by Chen and Clarke . 
If the hyperglycemic action of the Benadryl was removed 
in their experiments by the use of pentobarbita l, the 
epinephrine - induced hyperglycemia was reduced but this 
reduction was not statistically significant. It can be 
seen Jchat in our experiments, the reduction of only 4 mg . % 
was statistically significant, because it was all i n the 
same direction. Ho1'rever, t his minute reduction does not 
suggest any definite biologic significance. 
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It is important again to point out that ephedrine, 
Pitressin, and Pitocin were all effective in reducing the 
hyperglycemia. This is in agreement with the previous vmrk 
of Laurin ( 74) and Ellis ( 3 5). 'rhese agents all produce 
some circulatory change. Further evidence that the block-
ade of epinephrine-induced hyperglycemia is not limited to 
adrenergic blocking drugs is the report that ergonovine (61) 
will inhibit the response. 
H.egarding the effects of the adrenergic blocking 
drugs in dogs , the SY-21 and Lilly 08353 inhibited the 
hyperglycemia in dogs just as it did in rabbits. The report 
of a potentiation of the hyperglycemia by Susina and Unna 
(llh) using SY-28 in the dog may reflect a species differ-
ence since we found that this compound v>Jas effective in the 
rabbit. Hm'fever, in personal communication with Sus ina, I 
learned that the SY-28 was injected quite rapidly (about 30 
seconds), and precipitated a rise in blood sugar by its o~m 
action. Our technique was to inject the drug over a 3 minute 
period.. One wonders if this difference in technique was not 
responsible for their failure to elicit a blockade of the 
secondary hyperglycemia due to epinephrine. A slight initial 
hyperglycemia mi ght sum \vith a reduced epinephrine-induced 
hyperglycemia resulting in an apparent potentiation. However, 
the work of Harvey et . al. ( 61) wh ich vms discussed in the 
last section seems to indicate that the efficiency of the 
blocking drugs may be species specific. The absence of 
any effect with DH0 - 180 may be due to a dosage effect. 
It 1--va s used in a dose of 0.05 mg./kg . as opposed to a 
dose of 0.1 mg ./kg. used in rabbits but which was toxic 
in dogs. Susina and Unna (114) were unable to inhibit 
epinephrine-induced hyperglycemia in dogs with dihydro-
ergotamine injected in doses of 0.1 to 0.25 mg./kg . How-
ever, ~<vhen they increased the dose to 0.5 mg ./kg. , they 
did demonstrate a blocking of the blood sugar rise due to 
epinephrine. They report,ed that these doses also caused 
retching. 
The failure to reduce the lacticacidernia following 
epinephrine in dogs may be a circulatory effect. It could, 
of course, also be due to a failure to block at the muscle. 
In a ddition we should consider the possibility that it re-
flects an increased utilization of blood sugar or a de-
creased removal of lactic acid from the blood stream by the 
liver. These various possibilities will be considered in 
the discussion of the next section. 
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SUMIVlARY 
Although a majority of adrenergic blocking drugs 
have been shown to diminish epinephrine- induced hyper-
glycemia in rabbits, it has been observed that potent anti-
histamines and several pressor agents are likewise effective. 
A number of the available synthetic antihistamines have been 
tested for their effects on epinephrine-induced hyper-
glycemia and lacticacidemia in dogs. It was found that those 
compounds which have been knOW11 to be the most potent in 
antagonizing the effects of histamine on the bronchioles and 
intestine of guinea pigs, are also the most effective in 
reducing the epinephrine-hyperglycemia in rabbits. The 
effectiveness of the ant i .histaminic agents is not related 
to their ethylenediamine structure , their atropine-like, or 
their local anesthetic activity. Pressor agents such as 
Pitocin, Pitressin, and ephedrine diminished the induced 
hyperglycemia in rabbits. It is suggested that all these 
agents work by some non- specific effect, influencing the 
carbohydrate response to epinephrine only incidentally. The 
evidence suggests that antihistamines inhibit epinephrine-
induced hyperglycemia more readily in the rabbit than in the 
dog, which may reveal an important species difference. None 
of the antihistamines or adrenergic blocking drugs tested in 
the dog decreased epinephrine-induced lacticacidemia. 
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THE INFLUENCE OF ADitENERGIC BLOCKING DRUGS AND NEO NTERGAN 
ON EPI NEPHRINE-INDUCED EFFECTS ON GLYCOGEN, GLUCOSE UP'rAKE, 
AND OXYGEN CONSU!viPTION OF THE ISOLATED HE:l\'IIDIPHRAGM 
AND LIVER SLICE OF THE RAT 
It is felt that .before going into the experimental 
results of the next and last section of this series of 
studies, it \vould be advantageous briefly to review 'Ghe 
highlights of the literature on the mechanism of the 
epinephrine-induced hyperglycemia. That epinephrine causes 
a liver glycogenolysis is incontrovertable. The question 
is what part in this carbohydrate plethora is played by a 
decreased utilization and/or uptake of glucose from the 
blood stream. 
This has been the source of a great deal of con-
fusion in the literature. The main difficulty is that in 
the intact animal it is difficult to measure separately 
the glucose uptake and the glucose utilization, and the 
terms have become linked, when actually they should not 
be so. 
Cori (26) has marshalled evidence from which he 
concludes that epinephrine-induced hyperglycemia is in 
part due to a decreased utilization of blood sugar by 
muscle tissue. This conclusion is based on three main 
theses. 
l. The amount of glucose which he had supplied 
to normal rats in order to produce a hyperglycemia of similar 
magnitude and duration as that caused by certain doses of 
epinephrine, was such that it could not possibly be derived 
from liver glycogenolysis. 
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2. Simultaneou.s det;erminations of A-V blood 
sugar levels in man and rabbits have shown that for the 
same degree of hyperglycemia , the ! -V blood sugar differ-
ence was greater when the hyperglycemi a was caused by 
sugar administration than when it was due to epinephrine 
injection. This, however , was a measurement of glucose 
uptake, as has been defined in an earlier part of this 
dissertation . 
3. Colwell and Bright (25) have reported that 
~>Then epinephri ne and glucose were continuously i nje ct ed 
i nto amytalized cats, the non-protein R. Q. (instead of 
rising progressively as under identical co nditions with-
out epinephrine ) dropped to t he fat level V'T ithin 3-5 hours , 
and remained there o.s long ils the epi nephr i ne administration 
persisted . These anima ls excreted an i ncreasingly reater 
proportion of sugar adm i nistered . The authors concluded 
t hat epinephrine vias capable of suppressing glucose utili-
zation even in the presence of an increased supply. 
This theory of decreased uJci li zation of blood 
glucose has been a very provocative one , and many wo rkers 
have a ttempted experiments to verify or deny i Jcs validity 
(cf. Griffith (50) for extended references) . Most of the 
work has been performed on intact animals, and. the results 
obtained have been most confusi ng , for the utilization of · 
blood glucose has been shown to be i ncreased , decreased, 
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or unaltered by epinephrine. Each investigator is quite 
certain that his own view is correct. Leading among those 
investigators supporting the vie\'l that the utilization is 
decreased is Cori, and among those advocating increased 
utilization are Soskin and Griffith. Soskin (111) has been 
of the opinion that the met hod employed by Cori and others 
of comparing the hyperglycemia of injected glucose with 
that induced by epinephrine is unwarranted. They cite the 
experiments of Iviann and Iviagat rl ( 84) vvho claimed that the 
liver itself must use large quantities of injected glucose 
since the hepatectomized rats required only about 1/10 the 
amount of glucose used by Cori to simulate the blood sugar 
rise produced by epinephrine. It becomes a problem of 
whether there is any essential difference between the 
metabolism of exogenous or endogenous circulating sugar. 
Soskin and his co-workers (lll) claimed that one 
could not consider measurements of arterio-venous differences 
a valid estimate of blood sugar utilization unless, concomi-
tant measures of changes of blood flmv wer e made. Here 
again we have an example of the source for confusion in 
1vhich glucose uptake is called glucose utilization. They 
reasoned that an increase in blood flow could account for 
a decrease in utiliza.tion, and proceeded to measure the 
blood glucose A-V differences taking into account blood 
f low and hydration. They removed samples from the carotid 
47 
artery, femoral, portal, ~nd hepat ic veins. ~pinephrine 
was i njected intravenously at the rate of 0.12 mg. / kg ./hour 
i nto amytalized dogs and their results indicated that there 
was no evidence that epinephrine decreases the utilization 
of blood sugar by the mus cles of the hind l imb. 
Cori, Fisher, and Cori (3 2 ) upon revising ~heir 
experiments criticized Soskin's group in two main aspects. 
They claimed that Soskin ' s solution of epinephrine was not 
protected by antioxidants, and inj ected over such a long 
period of time that the solutions may have spoiled. They 
further noted that the blood flow gradually declined to 
extremely low levels in each experiment, indicating a poor 
physiological condition of the dogs . The method of record-
ing -c;he blood flow (one which removed 'che blood from the 
dog 's body and then rein j ected it) v-ms one which might have 
led to a gradual deterioration of the condition of the dogs 
and the circulation of the blood. 
Three years l ater , the Soskin group (109 ) repe ated 
their. studies using a different me t hod for recording the 
blood flow. Again, they could not demonstrate an increase 
in glucose uptake due to epinephrine when they considered 
the chcmges in blood flow in their calculat;,ions. The in-
creasEE i n blood flow were substantial , and tended to i n-
crease the glucose uptake rather th an decrease ii. 
Cori and his co:-worker~ (32) then decided to 
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_investigat e the matter a gain using measurements of blood 
flow. In amytalized dogs they noted that only 0.015 mg. 
of epinephrine/kg./hour caused a hyperglycemia ·of about 
the same magnitude as that obtained by Soskin with eight 
times that dose. In addition, they noted that this rate 
of injection not only produced a hyperglycemia without 
any change in blood flow through the leg, but also pro-
duced a steady hyperglycemia instead of the erratic 
changes noted by Soskin. Instead of measuring the A-V 
differences as compared to injected glucose, they measured 
the differences as compared to insulin, and noted that 
whi l e epinephrine caused an increase of only l-2 mg. %, 
insulin caused an increase of 10-25 mg. %. This is a rather 
peculiar comparison since the amount of increase of utili-
zation caused by insulin would probably vary with the 
dosage. The experiments, hmtever, are significant in that 
they afford. evidence that hyperglycemia could be induced 
without alteration in blood flow. 
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It was Corl's contention that the measurements of 
the b lood f low are not essential in evaluation of A-V differ-
ences. He showed that the error of i:. 1 mg. 1; for the determi-
nations of blood sugar was so great thut it is useless to 
calculate with the a ppropriate changes in flow. For example, 
a set of values of 143 and 138 for the arterial and venous 
blood glucose levels, respectively, would give a difference 
of 5mg. %. Assuming an error of l 1 mg. %>then a difference 
of 144-137 = 7 or 142-139 - 3 mg . % mi ght also be found. 
With a blood flow of 4 cc/ minute through the leg, the sugar 
retention in the 3 cases would be 120, 168, and 72 mg./ hour 
respectively. Hence with such a large error, the utilization 
c ould be shown to change even if it was exactly the same 
for thrE:e consecutive meo.surements . The best that can be 
hoped for by measurements of A-V differences may be a 
qualitative index. 
There have since qeen many investigators who have 
duplicated the experiments and results of both Soskin and 
Cori. There are two outstanding experiments which should 
be cited for their significance . Soga (106) showed that 
continuous administration of glucose inhibited the fall in 
blood glucose of hepatectomized dogs. If epinephrine was 
infused along with the glucose into such dogs, there was an 
increase in blood sugar and a decrease in muscle glycogen. 
In the hepatectomized dog, such a hyperglycemia could only 
be due to a decrease in glucose uptake and/or a decreased 
utilization. The finding that the muscle glycogen decreased 
does not aid in the interpretation, since it may be due to 
e ither or both of these possibilities . However, since epi-
nephrine did not prevent the fall in blood sugar in an 
hepatectomized dog which was not treated with glucose, there 
wa s the indication that epinephrine could only act in the 
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face of a g iven critica~ level of blood sugar . 
Another experiment of significance was performed 
i n unanesthetized humans by Jomogyi (107). He employed a 
dose of epinephrine of 0. 2 mg. subcutaneously , a dose so 
small that it did not alter the pulse rate or bloo-d pressure, 
and produced a rise in blood sugar of only 13 mg . %, an 
hyperglycemia equivalent to ·che ingest ion of 5 .0 gms. of 
glucose. A subject 1:1as f irst fed 50.0 gms. of gluco se 
without any epinephrine administered, and t.he A- V differ-
ences - in blood glucose following the <:tli mentary hyperglycemia 
were recorded . A fev•T duys later the subject went through a 
second test which differed from the first only in that the 
subject received 0.2 mg . of epinephrine, s ubcutaneously , ten 
minutes before t he ingestion of t he 50. 0 gms . of glucose. 
It was noted that the hyperglycemia result i ng from the com-
bined epinephrine and glucose was great.e r than that due to 
glucose alone . At the same time the _- V diff~rence was less 
in the hyperglycemi a due to epinephrine and glucose t.han in 
the hyperglycemi a due to glucose alone. This latter findi ng 
indica t.ed that the greater hyperglycemia when epinephrine 
was given in addition t o glucose was due to a decreased 
glucose uptake and/or utilization by the tissues . 
These data revealed another important bit of in-
format i on . It wa~ noted that with epinephrine plus glucose, 
the blood sugar rose to hi gher peale;; and 'chen dropped much 
mo re steeply thm1 the gluqose controls. This 1;·1as an in-
dication of a marked increase in insulin secretion, and 
the ever- present dynamic bala nce between insulin and epi-
nephrine . The result ing hyperglycemi a and glucose utili-
zation is nothing more than the result of an antagoni st ic 
action of these two substances . As indicated several times 
above, it may be that the results of some 'l:'lforkers showing an 
increase in utilization v-1as due to c.:.m increase in insulin 
secretion. On the other hand, the results of some in-
vestigators indicating a de crease in utilization could be 
caused by un addit ional output of adrenocortical hormone 
( 69 ) , for it shoul d be clear that epinephri 1e will act in 
the intact animal upon the existing endocri n e ::;tate of that 
i nd ividua l. Indeed, some of Soskin's (109 ) graphs indicate 
that there was some degree of hypoglycemia at the start of 
their experiments , suggesting that there may have been a 
good deal of circulating insulin. In addition, in Soskin' s 
experiments, the experimental design was such that glucos e 
\vi:lS infused, and after the return to normal the epinephri ne 
was injected. The hyperglycemia induced b y glucose infusion 
mi ght h ave caused large amounts of insulin to be released, 
which may not have been ent irely destroyed by the time 
e pi nephrine \'Vas administered, and the primc.:ry a ction of in-
sulin could counteract the effects of epinephrine , as shown 
in the isolated muscle stydy of Riesser (100). 
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In as much as the results are so variable regard-
ing the effects of epine phrine on glucose utilization, it 
appears to be almost impossible to predict the effect of 
a g iven inj ~ction. However, it is of interest to evaluate 
the various factors contributing to the end result. One 
of the ways of evaluating these factors is to place the 
tissue in isolation, and thus remove the various hormonal 
influences. 
There have been a good many studies on isolated 
tissue, but comparatively few studies on the isolated 
skeletal muscles alone, which in the opinion .of many, con-
tributes the greatest area of the utilization of carbo-
hydrate. 
Most of these experiments can be criticized in 
that the tissues have been severely i ujured in removing them, 
mincing and homogenizing . In order to minimize the trauma 
of preparat'ion, the rat diaphragm has been suggested by 
Gewnill (44) for these studies. Two I~raeli workers, 
Tuerkescher and ~ertheimer (117) presented an interesting 
study. They used rats that were first anesthetized with 
Nembutal. The animals were bled, the diaphragm was removed 
and placed in a Warburg apparatus. As a measure of glycogen 
synthesis, the difference in glycogen content between one 
t est sample incubated for 6 minutes and the other for 3 hours 
\vere used . Difference in glycogen fo l lowing the addition of 
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e pinephrine was measured by the difference in the glycogen 
content of 2 sarnp les after 3 hours of incubati on; one 
s ample being incubated in the usual manner, cmd the other 
\-vith e pinephrine added. Glucose vms present in the medium 
in a conce11'cration of 100 mg. %, a nd the experiment wc1s con-
ducted in an atmos phere of pure nitrogen . Glycogenolysis 
was measured by the decrease in glyco gen in 3 hours of 
incubation in a glucose free me dium. The addition of epi-
nephrine I-ICl at a concentration of 0. 3 3 gamrna/ ml. r egularly 
decreased glycogen synthesis by abo ut 441~ ; at 0 . 0033 gam1na/ 
ml., the effect disappeared, and at 0. 033 gwuma/ml. the 
effect \vas irr8gular . The decreased glycogen synet hsis in 
the diaphragms with epineph r ine added could be observed 
after one hour . The eff ect ~>vas blocked by ergotamine 
tartrate ( 8 .3 - 10 gamrna/ rnl.) which itself reduced the rate 
of muscle g lyco genesis . Therefore, the effect of ergotamine 
must have been due to a blockade of the a ction of epinephrine. 
It was of interest to note that at a concentration of e p i -
nephrine of 0 .33 garnrna/ml . t here vms an increase in glyco-
geno l ysis of 4 77&. This is to be compared 'vvith the decreased 
gl yco gen synth esis with epinephr i ne of 44%. This finding 
indicates tha t the apparent decrease in glycogen synthesis 
was p robably a reflection of an increased glycogenolysis due 
to epinephrine. 
Cohen (22) reported a series of experiments on the 
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effect of ep inephrine on glucose utilization in the isolated 
rat diaphragm . He was unable to demonstrate any effect of 
epinephrine added in doses of 50 - 100 gwmua in vitro. There-
fore , he injected e!Jinephrine in a dose of 1 mg ./kg., sub-
cutaneously into rats 40 to 70 minutes before removing their 
diaphragms. The tissues were incubated in an atmosphere of 
nitrogen containing 57& carbon dioxide to equalize the bi-
carbonate so l ution. The medium contained 0 . 2% glucose, and 
he measured the rate of anaerobic glycolysis. Si nce the 
lactic acid produced as a result of anaerobic glycolysis 
would release carbon dioxide from the bicarbonate i n the 
medium, a measure of the ca rbon dioxide released was a 
measure of the anaerobic glycolysis occurring within the 
muscle. 
The glucose entering the tis sue I-1]'()Uld pres umably 
be phosphorylated , and then either converted to glycogen, 
broken dmm. to lactic acid , or stored as hexosemonophosphate. 
Although Cohen found an accumulation of phosphate in both 
the control and epinephrine-treated diaphragms after i n -
cubation, he vvas unable to demonstrate any difference in the 
runount of a ccumulation of phosphates between these two groups. 
While the glycogen content of t he untreated diaphragms de -
creased after incubation \vi th glucose, the g lyco gen content 
of the epinephrine-treated diaphragms did not cha nge after 
incubation with glucose. Oddly, the glycogen value of 
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epinephrine-treated diaphragms did not change even vvhen they 
vvere incubated in the absence of glucose, although l a ctic 
acid was still produced!! One wonders what could have been 
the precursor for lactic acid. The lactic acid (measured 
by the carbon dioxide released and checked by chemical 
determination) produced by the epinephrine-treated diaphragms 
vms significantly less than that produced by the control 
diaphragms . From this, the author concluded tho.t there vlas 
a decreased glycolysis due to epinephrine. He claimed, since 
there was no change in the glycogen content of the epinephrine-
treated diaphragm before and after incubation, that the de-
creased rate of glycolysis was akin to a decreased rate of 
utilization of the glucose entering the tissue. bince there 
was no difference in the phosphate intermediates content 
between the cont.rol and epinephrine-treated tissue, the 
decreased glycolysis was also an indication of a decreased 
rate of glucose uptake. 
However, Cohen did not measure the rate of dis-
appearance of glucose from the medium. Since the glycogen 
value of the epinephrine-treated tissue did not change from 
the initial value fol l owing incubation, while it decreased in 
the control diaphragms, some of the glucose tc~en up from the 
medium must have been converted to glycogen. Therefore, it 
is possible that the rate of glucose uptake may not have de-
creased even though the rate of glycolysis de creased. 
im interpretation of these experiments is difficult 
to make. The observation that epi nephrine added in vitro in 
doses as hi gh as 50 - 500 e;amma produced no effect on any 
of the facets of glycolysis measured is most surprising . It 
a ppears that when epinephrine was injected into a rat before 
the diaphragm was removed and incubated, that an inhibition 
in anaerobic glycolysis did occur. A'c least in these ex-
periments, it. does not seem that the inhibition was due to 
an accumulation of intermedia tes, since they were not 
appreciably different from the controls. Cohen did demon-
strate that there. was no reduction of glycolysis in 
e pinephrine-treated diaphragms if they were incubated in 
hexose diphosphate, which indicates that t here was some 
interference before that particular step in the glycolysis 
chain. 
The finding that epinephrine added to diaphragL1s 
in vitro had no effect, led Cohen to another seri es of 
experiments ( 23) in an a tternpt to find the possible rae cha-
nism of action. He reasoned that either the epinephri11e 
1;vas transforme d into a more active compound some1;vhere in 
the body, or else in view of the existing knmvledge of 
hormonal balance, the epinephrine stimulated the hypophysis 
or adrenal cortex to activity, and this was the actual 
agent i nvolved. He repeated his experiments using 
hypophysectomized and adrenalectomiz ed rats, and his results 
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are quite interesting. I t \ H S observed that e pinephri ne 
injected into an hypophysectomi zed rat did not produce 
inhibition of glucose utilization, indicating that the 
indirect action of epinephrine was pro bably mediated 
throu gh the hypophysis. l~1oreover , this indirect a ction 
of e pinephrine is i ndependent of the adrenal cortex, s i nce 
upi nephri ne injected into adrenalectomized r ats still ex-
hibited the i nhibition. 
A Dutch investiga tor, Riesser (100), reported a 
study of the effect of epinephrine on the i solated rat 
diaphragm. Thi s study wa s not conducted in the Warburg , 
but in a flask kept at constant teruperature. In additi on , 
the preparation was a rib-diaphragm preparation , rather 
than a diaphragm alone. This type of pr eparat ion involved 
l ess cutt i ng 'of the muscle fib ers of the diaphragm, and 
presumably the presence of bone would not a ppreciably in-
fluence the ... ~ly co gen content of the muscle during i ncubation. 
After incubat i ng the tissue in oxygenated solution of 
phosphate-buffere d Ringer's so l ution containing 0. 5~0 gl ucose 
for 3 hours i n the pr esence of such mas sive doses of epi -
nephrine a s 50-100 gamma , the glycogen level was s een to 
fa l l. However , s i nce no measur ement of gl uco se or l a ctic 
a cid were made , there is no way of t elling \."Vhether this 
a ction was due to an i ncreased glycogenolys i s or an in-
hibit i on of glucose uptake . The author was of the op i nion 
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that both expl anations aR plied . He s hov,red that the muscle 
glycogen decreased even in the presence of insulin, and 
took this to mean that there was an antagonism of insulin 
by epi nephrine , s i nce the action of insulin is generally 
accepted to be t o increase glycogenes i s and to prevent 
glycogenolysis . 
As can be seen from the foregoing, the existing 
experiments \vi th the intact ani mal dealing with the e f fect 
of epinephrine on glucose uptake and utili zati on present s 
a rather confusing picture . If the reader will recall the 
wat er analogy given in the Introduction, the lev:e l of \'rater 
(blood sugar) in a sink (b lood stream ) could rise not only 
by incr easing the rate of wat~r i nflow from the faucet 
( l i ver gl ycogenolysis) but also by decreasi ng the rate of 
outflow from the sewer-drain (glucose uptake and utilizati on 
by the t issues) . It has already been po inted out that the 
rate of ~luc os e uptake and glucose utilization, if defined 
individually , can vary in.dependent l y of each other because 
of the ability of muscle and liver tissue to store hexosemono -
phosphate. In the intact animal it is qui te difficult to 
measure both the glucose uptak e and the glucose utiliz&t ion 
independently , and the best one can hope for it> to measure 
the rate of glu cose uptake from the bl ood stream by the 
tissues . The techni que for this measurement is t he deter-
mirat i on of the A-V di fference in bl ood sugar . However, when 
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this is donE:! , the glucose. uptake can be shovm to either in-
crease or decrease fo llowing epinephri ne admini stration . 
Some attempt has been made to correct for the changes in 
blood flow due to epinephrine on the theory that glucose 
spends less time at the cell membrane, and, therefore, l es s 
is absorbed , and the glucose uptake appears to decrease. 
On the other hand, one may consider that an increas e i n 
blood flow presents more glucose to the cell membrane per 
minute . In such a case, an i ncrease in uptake by dint of 
mass action effects rather than any enzymatic facili tation 
by epinephrine may be the responsible factor . However, 
despite correction for bl ood flow different l aboratories 
have shown the gl ucose U) take to increase or decrease 
following epinephrine i nje ction . 
It has been pointed out by Cori 's group (32) that 
the error in the determination of the A-V differences is 
such, that it is diffi cult to rely upon such measurements 
as quantit ative indicators of glucose uptake. 
It should be remembered that in the intact animal 
the influences of other hormones might play a role in the 
final observed effect . Thus epinephrine could increase the 
rate of glucose uptake by the tissues and at the same time 
stimulate the secretion of adrenocortical hormones by way 
of the anterior pituitary. The adrenocortical hormones are 
known to decrease glucose uptake. Thus, in Cori's experiments 
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in which small doses of e __ inephrine were used, the a ction 
of the adreno cortical hormones could overshadow the act ion 
of e pinephrine . On the other hand, in Soskin' s experiments, 
the doses of epinephrine used were relatively large, in 
\vh ich case the action of e pi nephrine could still be domi-
nant despite the presence of adrenocort ical hormone . 
Studi es on the i solated musc l e have done little 
to clarify the situation, priLarily because the rate of 
glucose disappearance from the mediwn was not measured . 
IVIost of the isolated studies which do not use the diaphragm 
are generally difficult to i nterpret because of the possible 
i n jury done to the tissues by mincing and homogenization. 
Ivlost of the studies with the rat diaphragm give some in-
di cation that the glucose utilization is decreased , but the 
available informat i on is so scant that no definite conclusions 
can be reached . 
A port ion of the experimental data in this section 
is based on the effe cts of epi nephri ne on the oxygen con-
sumption of isolated liver and muscle. It is believed 
appropriate , at this point, to discuss some of the outstand-
ing papers on the calorigenic effects of epinephrine in the 
i ntact animal. This discuss ion is by no means meant to be 
exhaustive , but is only meant to po i nt out the h i ghli ghts , 
and to place some type of order in a subject which is in a 
rather chaotic state . The reaaer is referred to the recent 
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review article by Griffi~h (50) for an excellent detailed 
bibliography. 
dministration of epinephrine in physiological 
dosage to the intact animal leads to an increased respira-
tory metabolism--an increased 02 utilization which is inter-
preted to be an increase in caloric production by the body. 
Thus one describes a ncalorigenic 11 action to epinephrine. 
Such a calorigenic activity is an intricate part of the 
"emergency theory" which Cannon has introduced to explain 
the diverse activities of the adrenal medullary hormone. 
Attempts to demonstrate a calorigenic action on 
isolated tissues have led to results so contradictory as 
to b e completely inconclusive. In an attempt to determine 
whether the hormone is a s pec ific or general stimulant to 
cellular metabolism, nearly all organs and tissues of the 
mammalian body, and some others have been tested in vivo or 
in vitro. These include the adrenal gland itself, blood 
cells, brain, heart, kidney, liver, nerve trunk, placenta, 
pituitary, sarcomas, skeletal muscles, smooth muscle, skin, 
thyroid, tumors (50). Also, mere separation into a pre-
dominant ly visceral or peripheral locus has been attempted 
by use of hepatectomized or eviscerate preparations or of 
single limbs (14, 53). Griffith, in surveying the situation 
in 1949 (51), says, 
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••• of the variable reports, some 52 rn<.:Ly be inter-
preted as indicating general stimulation, 24 
6.2 
describing inhibit i on, 29 i ndi ca ting no effect or 
at least no ne in t he a b s ence of the liver, and 11 
suggesting that the effect depends upon the concen-
trat i on of epinephrine, or of the availability of 
oxygen or presence or ab sence of functioning 
syrnpa thetic nerves. rr 
It will be he lpful, I be lieve, to mention briefly 
here agai n the Cori cycle, v;hich was dis cussed i n the Intra-
duct i on . Epi nephrine a ct s on muscle glycogen to cause 
g l ycogenolysis v·rh ich will produce a subsequent formation 
of pyruvi c a cid and l a ctic a cid . I:c1 the presence of 02, 
the Pasteur e f f ect will occur, and pyruvic a cid 1rJi ll enter 
the Krebs' oxi dative cycle, and will form C02 and H20, 
utilizing 02 i n the process . That this process may be 
involved in the cal origenic a ctivity of epinephrine is 
i ndi cated by the fact that very oft en i n isola ted tis sue 
preparat i ons where adequate 02 is present, t he R. Q. 
(C02/02) is equa l to 1. In the face of excess g l ycogenolysis 
and i nsufficient oxygen, l a ctic acid will be formed . In 
the ma~nal 3/4 of this lactic a cid is c a r r ied t o the liver, 
and converted to liver glycogen , V'Jhile 1/4 r ema i ns behind 
to be oxidized to give energy f or the reformation of 
creatine phosphate . The energy required for the conversi on 
of l a ctic a cid to liver glycogen , probably come s from f a t 
c ombust ion , again an oxi dative pro cess . Thus i n l ong term 
experi ments i-vith i ntact ani mal s , "Ghe R. Q. \vas that of fat 
co1nbustion (25) . The liver gl ycogen is s plit by epinephrine 
t o form bl ood glucose which i s transported to the muscle to 
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be converted into muscle. glycogen and the process starts 
a ll over again. The cycle may be represented diagramati-
cally as follows. 
Blood glucose > j 
Liver 
Glycogen A from 
fat oxidat ion in 
liver 
Muscle Glycogen 
1 
Pyruvic acid~ C02 ,L H2o 
Lactic acid ~ A 
Two factors appear to be rather well settled as 
will be shown below. First , that hyperglycemia produced 
by epinephrine is not sufficient to cause an increase in 
caloric output. Second, that muscular activity contributes 
only a very small fraction of the rnt:!tabolic response, and 
then only under conditions of acute severe stress. 
I should like to begin the discussion by giving 
a very brief resume of the early work in the field. The 
studies on the effect of epinephrine on the metabolism as 
evidenced by alteration in the quantity and character of 
the gaseous or respiratory exchange were initiated by 
Barcroft and Dixon in 1906 (6). By means of perfusion of 
the coronary system of an excised heart, and determination 
of the C02 and 02 tension of blood, they demonstrated that 
after addition of epinephrine, the oxygen consumption was 
increased 3 or 4 times. Bernstein and Falta found in 1912 
(9} that in man, 0.1 mg. - of epinephrine i njected subcutaneously 
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re.::;~ulted in a rapid increase in oxygen consumpt i on which 
reached its height 1 hour after the in j e ction. Anderes 
and C loe~ta , in 1916 (5) , demonstrated an increase in the 
volume of the blood ~hrough the lungs which accompanied 
the increa::>e i n oxygen absorption. Sandiford in 1919 
(103) was the first to demonstrate that epinephrine did 
not exert its effect through the t hyroid gland . This was 
confirmed by l•mrine . and Lenhart i n 1920 ( 85 ) in thyroid-
ectomized rabbits . Jumping for a moment to 1946 , De 
Visscher ( 119) showed that t hyroidectomy in the rabbit 
d i d not completely aboli sh the action of ep inephri ne on 
gas eous exchange unt i l 20 days after operation . Subse-
quent injection of thyro i d hormone returned the response 
to normal , providing . l arge doses of thyr oxi n were used . 
Small doses di d not return the response to norm~ l. He 
concluded that the action of the thyroid hormone \"Tas t o 
sensitize the tissues to epinephri ne calorigeni c activity . 
The f i r s t attempt to show that t he calorigenic 
act i on of epinephri ne was something over and above the 
mere i ncrease in blood. gl ucose vvas by Boothby and Sandiford 
in 1922 (12) . They had 44 experi ments on human subjects 
in which the i ncrease in hea~ production, ~ . Q. and blood 
sugar from the in j ection of 100 gm . of glucose was compared 
with the results obtained in 22 experiments followi ng 
subcutaneous injection of 0.5 mg . of epinephrine . It was 
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noted that the injection o£ glucose cau~ed a 9% increase in 
heat production for an increase of blood sugar of 105%, 
while from e pinephrine there was a 2CP;~ increase in heat 
production \vith only a 37)··~ increase in blood sugar, and 
less of an increase in R. Q. 
It was not until 1923 t hat Boothby and Sandiford 
introduced the term ncalorigenic action" (12). It was 
this paper which was classical for its well controlled 
ob servations in which the effect of muscular activity \vas 
ruled out, a variable which complic ated most of the 
preceeding reports. They used unanesthetized do gs which 
were trained to lie. perfectly still throughout the ex-
periment. They watched the dogs carefully making note of 
any movement a t all. To be sure of a permanent record 
of this t here \vere 2 pneumo graphs around the dog. The 
f irs t passed over the upper part of the chest just behind 
the fo relegs, in such a manner that the slight est move-
ments of the forelegs or head vvere indicated on the 
Kymograph t.racing . rrhe s e cond passed over the lower part 
of the trunk just i n f ront of the hind legs so that move-
ments of t he hind legs as vvell as those of the tail vvere 
recorded. It was found that the involuntary tvvitching 
of "che l eg 1ovhich occasionally occurred had no effect on 
the met abolic rat e . Many of the observations may have 
b een on sleeping dogs, since they had no vvay of telling 
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whether the dog was awake .. or asleep. 
Epinephrine was infused intravenously, at the 
rate of 0.6 to 2 .5 gamrna/kg ./rninute for 6 to 13 minutes . 
The rise in pulse rate, and respiratory rate, and respira-
tory volume paralleled the increase in metabolic rate. 
They postulated at this time that 'che effect of epinephrine 
was general on all types of cells, and since they had shown 
that the effect could not be at""Gributed entirely to an in-
crease in blood sugar they suggested that the metabolites 
of the utilized blood sugar may be involved. 
There are t 1vo other outstanding papers which 
should be mentioned, shmring that the calorigenic action 
of ep inephrine is something besides the effect of a hyper-
glycemia. Corkill, Dale and Marks shovved in 1930 (33) 
that e pinephrine injected into eviscerate cats caused an 
increased oxygen consumption. This con·cradicted the 
results of Sosk i n (108) of 3 years earlier \vho obtain ed 
the opposite result. The difference may possibly be ex-
plained by the work of· Cori ( 27, 28) on frogs, which 
shm'Ved that as the hepatectomized animals began to die, 
epinephrine lost its calorigenic action. This indicates 
that failure to obtain a calorigenic response in the ab-
sence of the liver, at least in "che frog, might actually 
be due to a failure of the animal , rather than the absence 
of the liver. Corkill 's -injection of e l) inephrine was made 
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!flUCh sooner than Soskin's ·injection and the metabolic rate 
fell faster than in Soskin's experiments. Hunt and Bright 
had shown earlier in 1926 (68 ) that tying off the liver 
of cats did not remove the calorigenic response to epi-
nephrine, a lthough it was significantly lower in the 
controls. Since in the fasted animals the only source of 
hyperglycemia is the liver, epinephrine produced its 
action without a hyperglycemia. The fact that the liver 
was not present in these cats, indicates that the source 
of the calorigenic response was probably from the· Krebs' 
cycle, or from the oxidation of lactic acid. Glycolysis 
is also an exothermic r eaction, and thus muscle glycolysis 
could have contributed to the calorigenic response. 
The possibility that epinephrine produced its 
calori genic response by some other means besides the blood 
glucose increase, first suggested by Boothby and Sandiford 
in 1923 (12) was given due consideration by Cori and Cori 
in 1928 (2 9 ) i n their work on fasted rats. They gave epi-
nephrine subcutaneously in a dose of 0.02 mg ./100 gm. of 
body weight. They found that 3 hours after the epinephrine 
was injected, the total body glycogen , with the exception 
of the liver , fell 57 mg. They calculated that if the 
glycolyzed muscle glycogen was completely oxidized, 57 mg . 
should produce an R.Q. of 0.74, while the R.Q. actually 
observed was 0.715. Colwell and Bright (25) also 
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demonstrated that if experiments on cats lasted for 3 hours 
epinephrine infusion produced a fat R. . Q. They therefore 
concluded t hat the increase in oxygen utilization \·vas not 
entire l y due to the oxidation of glycogen, and suggested 
that it mi ght be the conversion of lactic acid to liver 
glycogen . In a later work in 1931, Cori and Bu chwald (2 8 ) 
expounded upon the me chanism. They explained that Meyerhof 
had shown that for each 02 equivalent of 1 mol of lactic 
acid used above the basal oxygen conswnption, 2-5 mols of 
lactic acid may be reconvert ed to glycogen . Since epi-
nephrine caused an increase in muscle lactic acid as 
well as an increase in caloric output, it was natural to 
think of the two as having some connection. If there was 
some connection, then epinephrine injection in frogs should 
cause less lactic acid to appear under aerobic than anaerobic 
conditions. A reference to previous studies showed this to 
be true. Whereas anaerobic conditions caused an excess of 
306 mg. of lactic acid per kg. of frog, aerobic caused an 
excess of 169 mg./kg; thus creating_a difference of 137 mg . 
He calculated mathematically that 25.3 cc of oxygen were 
needed to oxidize the part of the excess lactic acid that 
was slated to become oxidized (4:1). In other words , the 
frog should have consumed an extra wnount of 25.3 cc of 
oxygen/kg. to oxidize the lactic acid. They put this to 
the test in immobilized frogs giving 0 . 05 to 0.1 mg. of 
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epinephrine subcutaneously. They computed that the total 
extra oxygen utilized during the 3 hour period was 28 cc/kg . 
of frog . This, as can be seen, compared favorably with the 
theoretical 25.3 cc, which he had previously calculated. 
Thus they concluded that the effects of epinephrine in the 
frog inducing its calorigenic response was mediated through 
the increased muscle glycolysis causing an increased lactic 
acid production and the subsequent oxidation of lactic acid 
and the reconversion to muscle glycogen. 
However, the lactic acid oxidation provided energy 
for the reconversion of muscle glycogen only in the frog. 
In the mammal, almost the only place the lactic acid can be 
converted to glycogen is in the liver, and it is highly 
probable that iri the mammal the source of energy is from the 
conversion of lactic acid to liver glycogen. Cori has con-
sequently shm'ln that the oxidative energy required to con-
vert the lactic acid is derived from fat oxidation in rats. 
He has shown that in the 24 hour fasted rat (29) the in-
crease in heat production is at the expense of the fat 
combustion following epinephrine. He showed this by deter-
mining the urea nitrogen, and finding it unchanged from 
the control, which indicated that the protein was not 
being utilized. The R. Q. . of 0.715, when only fat and 
carbohydrate are being used, can be shown mathematically 
to be due 99% to the combustion of fat and 1% to the 
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combustion of carbohydrate. In the following paper ( 30) 
he described the effect of epinephrine injection i n the 
rat in the postabsorptive state, and showed that of the 
total increase of heat production, the breakdown of fat 
contributed most of the calories; t h e increase in f at 
calories 1.vas greater than the increase in carbohydrate 
calories. 
In the last paper of this series (31), Cori 
showed that in rats which vlere absorbing glucose from the 
alimentary canal, the extra calories follo1ring epinephrine 
inject ion v-Iere furnished entirely by fat , aespit e the in-
crease i n blood sugar level. There has been tendered no 
explanation of t his phenomenon , and it is not knovvn if 
the epinephrine affects fat metabolism directly or in-
directly. 
This theory would sc.:rve to explain some of the 
reports of failure to elicit a large calorigenic r esponse 
in the hepatectomized animals. Since the reconversion 
of lactic acid takes place only in the liver, in the same 
area as fat oxidation , a ma jor source of the calorigenic 
response would be removed with liver ablation. 
From 1927 to 1939 Griffith and his colleagues 
published a series of papers dealing with the effect of 
e pinephrine injected arterially ~G o the hind limb of an 
ane st hetized cat (52 , 53, 54, 56). He as sumed that 
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practically all of the epinephrine vmuld be used by the leg . 
He tried a variety of dosages ranging from 0 .002 gamma to 
2 gamrna/kg ./minute for 5 minutes and found that i n all 
cases there resulted a de crease in blood flow and a decrease 
in oxygen consumption of the hind l i mb . He took this to-
gether 1.vith his earlier negative ;:)tudies in the isolated 
limb and muscle as indicating that epinephrine did not 
produce its increased oxygen utilization by acting on 
peripheral tissue. In 191~7 Griffith and his co-workers 
(57} shifted the injection to the intravenous route. They 
injected doses varying from 0. 5-8 gWJl . .ma/ kg. / minut;.e for 5 
minutes. They found that the rate of blood flow through 
the leg was either increased or decreased , but on the 
average, was i ncreased; maximally by the smallest dose 
and least by the largest . Glucose retention by the tissues 
of the leg was invariably i ncreased as was the lactic acid 
level in the blood, whether flow rate \'las increased or de-
creased. The oxygen utilization of the blood was found to 
vary directly with the rate of blood flow. They concluded 
that neither a carbohydrate plethora nor an increased 
lactic ac i d output appeared to have an effect on the 
respiratory metabolism of the leg tissues, at least under 
the conditions of their experi ment . 
In 1949 (51}, the same 1.vorkers repea'ced their 
G}q)erirnent, this time i ncJ_uding a measurement of arterial 
7? 
blood pressure, leg volume ., and other changes resulting 
from epinephrine injection and glucose injected in amounts 
sufficient to produce an equivalent hyperglycemia. 
Epinephrine was injected at the rate of 4 gamma/ 
kg./minute for 5 minutes and glucose at the rate of 50 mg./ 
kg./minut e for 5 minutes. They .reduced a hyperglycemia 
of 77 and 82 mg . % respectively. Glucose transfer in the 
leg was increased by 120% by epinephrine and by 88% by 
glucose indicating that epinephrine influences blood sugar 
uptake. The average eff ect of epinephrine on blood flow 
v-ms to increase it about 3% whi l e glucose increased it 28% . 
Again the effect was variable. The leg volume decreased 
markedly when the blood flow increased. The arterial 
pr essure rose wit h the blood flow. The oxygen utilization 
a gain va ried with the blood flow and not with the rate of 
g l ucose uptake. Thus the injection of glucose increased 
the oxygen consumption 19% while epinephrine increased it 
5%. At this time Griffith attempted to explain the 
diverging results. 
He sur;gested that an increased influx of 
carbohydrate into the tissues of the leg stimulated the 
r f; s piratory metabolism by the s pecific dynamic action of 
carbohydrate. Increased C02 formation caused vasodilation 
resul ting in an increased blood flow and in an increased 
02 supply. This was ~hown by the glucose infusion. 
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In the epinephrine in.fusiorl:, vasoconstriction 
of varying degrees occurs depending on the tissue con-
ditions in the anesthetized animal. Arteriolar con-
striction could be sufficient to block passage of the 
red cells, but still permit a flow of pl asma of high 
glucose content. Glucose could then enter the tissues, 
but no 02 would be available for utilization. Variations 
in the degrees of vasoconstriction could then account for 
the variable amounts. However, it should be borne in mind 
that this situation holds for the experimental conditions 
t hat Griff ith used and might not apply to the unanestheti ~ed 
animal. 
The outstanding objection t o this theory is that 
one would expect an increased 02 utilization in the muscle 
after the epine phrine had worn off. However, Griffith's 
measurements extended to 30 minutes after the injection of 
epinephrine and there \'las no indication of a subsequent 
increase in 02 utilization. However , if Griffith's 
postulate is true the decreased 02 presentation to the 
tissues would prevent the oxidation of lactic acid and 
pyruvic acid in the leg and all oxidation would occur in 
the liver; thus, giving an increase in 02 utilization in 
the body as a whole without an apparent effect in the 
limb. Thus, the results of Griffith are not in conflict 
with the theory of Cori. 
74 
The literature ,dealing with the. effect of epi-
nephrine on 02 consumption in vitro presents a confusing 
icture, indeed. As mentioned in the beginning of this 
discussion, a lmost all organs have been tested. A com-
plete bib liogra hy is given by Griff ith (5 0) and indicates 
that in a lmost every tissue epinephrine may cause 02 con-
sumption t o go up , down, or stay the same. For example , 
the following re ports .resent evidence for increase in 
o2 utilization following ep ine phrine i n the liver: 
Gotts chalk (47 , L1-8) , Masing (86 ), Nukariya (96 ), Reinwein 
and .S inger ( 99 ), Smirnova and Sverev ( 105); and in muscle: 
Ahlgren (3 , 4), and Macht and Bryan (83). Deivleio (87) 
has cla imed that the 02 consumption of liver rema i ns un-
changed after epinephrine administration and Paasch and 
Reinwein ( 98 ) , Nakao ( 90) , Schattenstein and Zyukova ( 104) , 
Dei'leio ( 87) , and Walaas and Walaas ( 121) have made simil ar 
claims f or the effect on mus cle . On the other hand, there 
have been the reports of De Cloedt and Van Canneyt (21), 
Euler (3 8 , 39 ), Neuschlosz (91), and Abderhalden (l) that 
e !)ine~hrine causes a rise in 02 consumpt i on in isolat ed 
liver ~reparations. Similar claims t o an increas e have 
been made for mus cle by De Cloedt and Van Canneyt (21), 
Klein (76 ), Goor (46) and Euler (3 8, 39 , 40). Almost 
a l l of the te chniques v-rere very similar and little if any 
explanation can be offered for the amazing variety of 
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results. In most cases the only variable between the 
various experiments was the dosage of epinephrine used, 
but the literature dealing with the effect of the dosage 
of epinephrine on 02 consumption is as confusing as the 
literature cited above . (See Griffith (50) ). Griffith, 
himself, (50), stated that he is, 
" ••• unable to evaluate such evidence except from 
a quantitat ive point of view; from this stand-
point it may be pointed out again that if those 
results indicating no effect or a decrease in 02 
consumption are set off against those which in-
dicate an increase the first two will be found 
to outnumber the third ••• we have seen no 
acceptable or accepted explanation for so many 
failures to show a stimulatory effect." 
In view of the fact that Griffith, a renowned 
investigator in the field, and probably many others like 
him, can on _y use the force of numbers to give weight to 
the answer to this problem, it is hoped that the data set 
forth in this section will serve to add weight to one side. 
Also , some of the observations made in the experiments 
with epinephrine alone, may give some clues as to the con-
flicting results. 
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I NTRODUCTipN TO EXPERIMENTAL WORK 
The fore going review of the literature has in-
dicated that although some or der can be placed in the 
rather confusing results obtained on the effect of epi-
ne phrine on carbohydrate metabolism in vivo, the con-
glomeration of results in vitro are so chaotic that any 
experiments wh ich l end weight to one or another side of 
the i ssue are believed to be valuable in a final classi-
fication of the mechanism of action of the response. 
That epinephrine produces a rise in blood sugar is in-
disputab le, as is the fact that this rise is due in a 
l arge measur e to the conversion of liver glycogen to 
blood glucose. One of the most important questions is 
whether the rise is due, in part , to a failure of the 
t i ssues, particularly muscle tissue, to remove glucose 
from the blood, and/or to utilize the glucose once picked 
up. 
The previous sections of this the&is have un-
covered some i nteresting observations. First, that the 
adrenergic bl ocking drugs decrease the hyperglycemia in 
animals, but fail to show any effect on the lacticacidemia 
resulting from epinephrine injections, at least in the dog. 
This may be interpreted in several ways: 
l. The blocking agent exerts its effect on liver 
g lyco genolysis and not muscle glycolysis. 
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2 . If the hypothesis offered above (that epi-
nephrine causes part of the hyperglycemi a by decreasing 
the rate of glucose uptake and/or glucose utilization) 
is true, then the blockirig agents might act by removing 
that effect of epinephrine. 
3. The blocking agent could reduce the effect 
of epinephrine on both liver and muscle glycogenolysis. 
In this case , the failure to block the l act icacidemia 
mi ght be due to a circulatory accumulat i on of the lactic 
acid which is still being produced. 
The other observat i on is that antihistamines 
which had formerly been thought of as fairly s pecific have 
now been shown to block e pine phrine-hyperglycemia in the 
rabbit, although this effect was not demonstrated by most 
compounds in the dog . One v.ronders if the effect of these 
antihistamines might be species specific. 
It wa:::> thought that one of the best methods to 
shed some light on the answers to some of these problems 
was the ~;~'arburg technique for the study of isolated 
tissues . 1he rat Wi.:.LS chosen as the best experimental 
animal , since as Gemm i ll (44 ) f'irst advocated , in rats 
weighing less than 180 grams, the diaphragin is rarely 
thicker than 0 .5 rnm . a llowing for easy transfer of oxygen 
i n the reaction flask . The rat diaphragm has been used 
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~lmost exclusively by other workers for the study of 
muscle metabolism with preparations other than mince. 
The experiment v1as desi gned to run in the 
pr e sence of a high glucose environment. For this reason 
the tissue was bathed in a medium containing 200 mg . % 
glucose. The experiment was further designed so that in 
the course of a single experiment on muscle it was possible 
to measure the glucose uptake, glycogen synthesis and R. Q. 
(hence glucose burned). The summation of all these measure-
ments make it possible to get some insight as to changes 
in carbohydrate balance under the influence of epinephrine 
and under the influence of blocking drugs. Experiments 
measuring the rate of liver glycogenolysis and oxygen con-
sumption were also included, in order to help explain some 
of the effects of the blocking agents. 
The adrenergic blocking drugs, DH0-180 and SY-21, 
were chosen for study . The former was chosen because it 
was effective in such lov1 dose in rabbits and was \vithout 
appare nt effect in dogs. The latter was chosen because 
it is known to be a potent bloc ~cin g drug when tested on 
the other eff ects of epinephrine, yet only succeeded in 
producing a partial blockade of the hyperglycemia in both 
rabbits and dogs. In addition, it seemed desirable to 
se l ect two chemical types of adrenergic blocking drugs; 
DH0-180 belonging to t he ergot alkaloid class, while 
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SY-21 is representative of the 2-haloalkylamine type. 
Neoantergan was chosen as a representative o f the anti-
histamines since it was so effective in rabbits, and 
has been considered to be one of the most specific 
antihistamine drugs. 
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A. The rat diaphragm . 
For these experi ments male albino rats of the 
Sprague - Dawley strain 1-ver·e used . They were supplied by 
-r,he Cha rles Ri ver Breeding Laboratory. Only rat8 weigh-
ing as to 110 gms . were utili zed . ; ll animals were 
allowed to rest as quiet l y as possible for at least one 
hour prior to c.:m experiment . fter all the a pparatus 
was prepared and the soluti ons added to the flask, the 
rat was quickly removed from its cage and killed by 
decapitation . The blood vvas allowed to drai n for 30 
seconds , after which a mid-ventral i ncision was made in 
the s kin and the muscle from the urinary aperture to 
the clavicle . The diaphragm was freed from the abdominal 
viscera by cut~.,ing t he hepat i c ligament and the other 
omenta close to the diaphragmat i c musculatur e . The 
sternum was clipped 1rJ"ith a force ps , and the lateral \valls 
of the diaphragm were freed from the rib cage by cutting 
close to the inner wall of the r i bs . The sternum was 
then cut , and t he dic.:lphragm was freed from the lungs by 
cutting the pl eural attachments close to the diaphragm. 
The dorsal wa l l was f r eed by cutting close to the dorsal 
body 1-vall. The diaphragm vms thus removed and placed 
i n a petri dish filled with cold phosphat e-buffered 
en 
saline (described below). In order to keep the saline 
cool, the petri dish was rested on an ice bath. The 
central ligamentous portion was carefully dissected out 
together with all other visible tissue other than 
muscle, and then the organ was finally bisected by 
cutting the short connecting strip that attached it to 
the remaining portion of the sternum. To this time, the 
only place the tissue was grasped was by the attached 
portion of the sternum. This method of dissection 
allowed a minimum of manipulation and cutting of the 
diaphragm itself. 
B. The rat l iver slice. 
Rats used for the experiments on liver slices 
were killed by the same method as de::;cribed above. The 
abdominal viscera were exposed as detailed above and the 
ventral lobe of the liver was quickly excised and im-
mediately placed in a chilled Stadie-Riggs microtome. 
Sections of 0. 5 mm. \'Wre immediately cut. The first 
section was discarded, and the remaining sections were 
i mmediately placed in a petri dish filled with ice-cold 
phosphate-buffered saline and set in an ice bath until 
the succeeding portions were cut. 
The medium used was a phosphate-buffered saline 
recommended by Tuerkischer and Wertheimer (117) as a 
convenient simple medium which readily supports glycogen 
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synthesis. It consisted of: 
O. 741~ saline 
0. 0181; Na2HPO 4 
0 .003% NaH2Po4 
Glucose was added to this medium just before it 
was added to the flasks in amounts such as to have a final 
concentration of 0.2% glucose. This mixture gave a pH 
of 7.1 which was altered to 6.95 when epinephrine was 
added. 
The direct method of Harburg ( 118) tvas used 
to det ermine the rate of oxygen uptake in an atmosphere 
02 
of oxygen, Qo2 , and the rate of carbon dioxide production 02 
in an atmosphere of oxygen, Qco2 • To this end, 0 .2 ml. 
of 20% KOH was added to the center well of those flasks 
02 
which were to be used for the measurement of Qo2 • The 
lip of the well was lined with grease to prevent leakage. 
At this point, the appropriate amount of blocking agent to 
be tested was added and followed by an amount of medium 
sufficient to make a final fluid volume of 2.0 ml. This 
volume included the 0.2 ml. of KOH added to those flasks 
02 
measuring Qo2 • The flasks, of course, were all prepared 
before sacrifice of the animals. As soon as the hemi-
diaphragms or liver slices were added to the flasks, 0 .2 
ml. of epinephrine (see below for concentrations) freshly 
removed from the refrigerator, was added to the side arms. 
83 
The side arms of the con~rol received phosphate-buffered 
saline prepared with exactly the amount of a cid as was 
used to make up the epinephrine solution, so t hat both 
t he control and experimental tubes had ostensibly the 
same acid solution added to them. 
Following the completion of these preparations, 
the flasks were attached to the manometers, and thl::l entire 
fitt ing was p l a ced in the -'iarburg water bath which was 
maintained at 37°C. ·The total time from the first decapi-
tation to the last placing of seven manometers and a 
thermobar into the bath was about 20 minutes for the 
experiments on the diaphragm, and about 15 minutes for the 
liver experiments. 
';lhen all the flasks vvere in the bath, rubber 
tubes leading from an oxygen supply tanl< vwre attached to 
the side arms, and the flasks were flushed with 100% 
oxygen for 10 minutes . During this time , the shaker 
a pparatus wa~ set in mot ion at 90 strokes/minute. After 
10 minutes the oxygen inlet tubes vrere removed , all cocks 
were closed, and an additional 5 minu·ces was allowed for 
further equilibration . At the end of this period, the 
cocks were opened and epinephrine was tipped in. The 
manometers were then zeroed off and readi ngs were taken 
every 10 minutes for 2 hours i n the earlier exp~:;;riments 
a nd every 30 minutes for l hour in th8 later experiments . 
On a given day, , the manometer setup consisted of 
a thermobar (for measuring changes due to atmospheric con-
ditions, conta ining everything but the diaphragmatic 
tissue ) t wo or three pairs of manometers , and two additional 
manometers which were removed immediately after the equili-
bration. It v1a s from these last two manometers that initial 
values for muscle glycogen , glucose concentration, a nd 
liver glycogen were taken. It was believed tha~ this method 
for obtaining initial values -vvould control the eff ects of 
handling the tissue. In order to further this control, the 
manometers were not always set up in the same order, i.e ., 
the earliest excis ed tis sue was not always placed in the 
first flask. 
The epinephrine used was pure 1-epinephrine base 
(supplied by Parke-Davis, Co.). I t was first made in a 
concentration of 1:1000 using distilled water and dilute 
HC1. Further dilut ions were prepared from this stock 
solution by diluting with phosphate-buffered saline. In 
order to determine the best dose of epinephrine to be used, 
the following concentrations were employed with the dia-
phragmatic tissue. 
-5 
1. 6 X 10 M. 
- 6 
1 .. 6 X. 10 l\i . 
- 7 
1. 6 X 10 Jlli . 
These concentrations refer to the final concen-
tration i . e., after the epinephrine was tipped into the 
flask. 
N-9-Fluorenyl-N-ethyl-2-chloroethylamine (SY-21), 
dihydroergocornine {DH0-180), and Neoantergan were the 
b locking drugs selected for this study. The final concen-
tration decided on was that which was calculated as equal 
to or slightly below the blood concentration effective in 
blocking or reducing epinephrine-induced hyperglycemia in 
the rabbit, if all the dose injected were equally dis-
tributed throughout the blood volume. These concentrations 
were: 
0-5 SY-21 -- 1 M. 
DH0- 180 -- 10-5 M. 
Neoantergan -- 10-4 M. 
Again, these concentrations refer to t he final 
concentration aft er mixing with the medium. The solutions 
of blocking drug were prepared by starting with the dry 
sal t i n the case of SY-21 and Neoantergan , and a stock 
so l ution of DH0-180, containing 0.5 mg ./ml. They we~e 
prepared f r esh and diluted "l'rith phosphate-buf'fered saline 
on the morning of a given experiment and placed in the 
r efri gerator until ready for use. 
At the end of one or two hours, the manometers 
and flasks were removed from the bath and the flasks were 
86 
quickly detached. The tissue was removed, blotted dry on 
filter paper , quickly rinsed in iced phosphate-buffered 
saline, blotted dry again and weighed in a Roller-Smit h 
balance. The tissue vms placed in 1 ml. of 30% KOH and 
th.en the glycogen content determined by t he method of 
Good, Kramer and Somogyi (45). The glycogen is expressed 
in terms of wet tissue weights. A 0.2 ml. aliquot of the 
medium was analyzed by the micromethod of Somogyi (45) for 
· the glucose concentration and an additional aliquot vms 
reserved for the determination of pH. In early experiments, 
0.1 ml . aliquot was used for the determination of l actic 
acid by the micromethod of Barker and Summerson ( 8 ) , but 
unde r these aerobic conditions, there was insufficient 
l actic a cid produced to be detected by this method in my 
hands. 
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Drug li sed 
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Effect of Various Blocking Agents on £pi-
. nephrine-Induced Effects on Carbohydrate 
Metabolism i n the Isolated Rat Diaphragm. 
1) Effe ct of Epinephrine 
a) R. Q. - 1.00 
b) Glucose uptake - increases 
c) % accounted for- decreases 
d) Glucose burned - increases 
e ) Glycogen increases - decreases 
f) Glucose uti l ized - decreases 
Interpretation - The finding that under the influence of 
epinephrine the diaphragm formed less glycogen can be 
i nter preted as either a decreased glycogenesis or an in-
creased glyco l:rsis. The \'fork of Tuerkischer and Wertheimer 
(117), which has been discussed above, suggests that the 
latter po::;s ibility is more nearly correct. 'rhus, at the 
same time that epinephrine caused an increase in glucose 
uptake it decreased the total amount of the glucose uptake 
which was a ctually utilized. This indicates that there 
was an accumulation of some intermediate product. The 
evidence presented by other workers suggests that this 
product was hexosernonophosphate (see discussion). 
2) Effect of SY-21 plus_~inephrine 
a ) R. Q. - 1. 00 
b) Glucose uptake - Unchanged 
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c) » ac counted for- Unchanged 
d ) Glucose bur ned - " 
e) Glycogen i nc rease - " 
f) Glucose utilized - 11 
Inter pretation - All the eff ects of euinephrine on the 
a s pects of carbohydr ate metabolism which have been 
measured were blo cked by SY-21. · 
3) ~ffe ct of DH0-180 plus ?pinephrine 
a ) R. Q • - l • 00 
b ) Glucose uptake - increas ed 
c) % accounted fo r - decreased 
d ) Glucos e burned - increas ed 
e ) Glycogen i ncrease - decreased 
f) Glucose utili zed - decreased 
Interpretat i on - All of the effects of epi nephri ne on the 
aspect s of carbohydrate metabolism which have been meas ured 
rema i ned after treatment with Dl-I0-180. 
4) Effect of Neoant er gan plus ~pinephrine 
a ) R. n . - 1.00 
b ) Glucose uptake - Unc han~ed 
c ) % accoun~ed fo r - de creased 
d ) Glucose burned - increased 
e) G y cogen increase - i ncreased 
f ) Glucos8 utilized - decreas ed 
Interpretation - The only explanation that can be offered 
f or the failure of the glucose uptake to rise following 
epi nephrine is the wide variability of the data. It is 
believed that a larger series of experiments would show 
thi s gluco·se uptake to rise. With the exception of this 
phase all of the aspects of carbohydrat e metabolism which 
have been measured persisted after treatment ·with Neoantergan. 
If the increase in glucose uptake is found to be truly blocked 
by Neoant ergan, it may offer an explanation for the potenti -
ation of epinephrine-induced hyperglycemia seen in dogs. 
If the elevated blood glucose is not r emoved at an acceler-
ated rate such as is apparent in these experiments, the 
blood glucose wi ll rise still higher. 
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•f f ect of Grad~d Doses of Epinephrine 
on Oxygen Utilization of the Isolated 
Rat H8midiaphragm During the First and 
3econd Hours. 
Interpr~tation of Results 
Epi nephrine in a concentration of 1. 6 X lo-7 Iv1 
did not alter the oxygen conswnption during either the 
fi rst or second hour . However, a ten-fold increase in 
concentration signi fi cantly increased the oxygen con-
sumption during both the first and second hours. A 
hundred-fold increase in concentration, i.e. 1.6 X lo-5 M 
also increased the rate of oxygen consumption during both 
the first and second hours, but did not increase the r ate 
above that with 1 . 6 X 10-6 M concentration. It was there-
fore decided t hat a concentration of 1. 6 X 10-6 M of 
epi nephri ne woul d be used. This concen~ration has been 
shown by other workers to produce maximum glycolysis in 
the iso lated liver (107). 
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The Effect of Epinephrine (1 . 6 ~ lo-6 M) 
on Oxygen Consumpt ion of the Isolated Rat 
Hemi diaphragm During the Second Hour . 
Interpretat i on of Results 
Duri ng the second hour , the rate of oxygen con -
sumption of the control diapn.ragrns fell sli ghtly but s i g-
nificantly as cornpctred t o ·che control rate of the first 
hour . Whe n epinephrine was added to the medi um , the 
Lean rate duri ng the second hour was also less than the 
mean rate for the first hour vvith epi nephri ne . However , 
the variability i n the response was so l arge , that this 
decrease was not stat i st ically sig.ni ficant . Thi s s e cond 
hour oxygen consumption rate vvi t h ep i nephr i ne 'l:vas still 
si gnificantly hi ghe r than the controls during t his .~ e riod , 
but had faJ.len to the po int 1-vhere it vvas not significantly 
d i ffe r ent from the controls of t he f irst hour . Hence, 
statistically , one cannot demonst rate any difference be -
tween the com::.rol rate for the first hour and the rate wi th 
epi nephri ne for the se cond hour . 
It is suggested t hat thi s i s an indication of a 
begi nning failure of the action of epinephri ne so t wt t he 
rate begi ns to approach normal. One cl ue to explai n the 
d rop in oxygen utilization is suggested by the R. Q. It 
will be noted ~ 1ut t he a .Q. of the cont rols rose du~ing 
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·che second hour to 1.07 f;rom 1.00. This suggests a shi f t 
during the s econd hour from glucose oxidation exclusively 
t o an oxidation of glucose with simultaneous fat and/or 
protein storage . It is bel i eved that, in this case, it 
is probably fat . Chernick , l'"lasoro, and Chaikoff (20a), 
using cl4-labeled glucose , have dernonstru.ted that the 
isolated rat diaphragm i s capable of converti:ng glucose 
to fatty acids . The storage of fat during the ::;econd 
hour by converting the glucose to fat ·would release some 
oxygen from internal metabolism which could be utilized 
in the place of external , or supplied oxygen . In such 
an instance, the rate of oxygen utilization would tend 
to decrease from external measurements . Similarly, in 
those diaphragms treated with epinephrine , t he R. Q. rose 
to 1.04 . This can again be explained as above, by the 
storage of fat. It will be noted that in tlwse diaphragms 
incubated with epinephrine , the R. Q. did not r ise to the 
1.07 of the controls. It is likely that under the in-
fluence of epinephrine, there was an accumul ation of 
hexosemonophosphate during the first hour . During the 
second hour , as has been hypothesized, the effect of epi-
nephrine begins to decrease, and this hexosemonophosphate 
is then oxidized . Thus , the epinephrine-treated diaphragms 
use more oxygen during the second hour than the controls, 
and the H. Q. is ke,pt lower~ . Further evidence in 
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substantiation of the fail.ure of epinephrine act ivity 
during the second hour is offered in t he section dealing 
with "Effect of epinephrine on glycogen synthesis in the 
i solated diaphragm. 11 
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~J lne)hrin~ - Induc ed C a1ori ~enic bffect on 
the Isola ted 1.:Ca t Hemid iaphragm 
Dru;; ,f of 02 p l ' 1 
Us ed EXj_JtS U t i 1 i za ti on v s .. vs . 
ml / gm/ hr2 control con trol 
"'S" Ep i . c ~pi. 
Contro l 21 1.107 
I 0. 200 r 
·p ine )hrine 22 1 . 383 
1. 6 ' 10- bk I 0 . 19~- < 0 . 01 
SY - Ll 9 1. 104 
lo-5 H I o . 179 ) 0 . 5 ( 0.01 
SY ~ 2 1 9 1.200 
J. I 0.2 10 0 . 3 ( 0 .05 I 
:8.:~ inephrine ) 0 . 02 
JJH0-18 0 9 1. 254 < o.o~ <O .l 
1o - 5r:: / o . o8L~ >0.02 'j 0 . 05 
0110 -18 0 9 1 . L~2 1 
I J. 0 . 08 0 ( 0 .01 }0 . 5 I 
Ep ine ~)nrine 
1.' e oan te r :::;·an 15 1.161 1o-I~~.I ,_, I 0 .23 0 o . ~. ( 0 . 01 
Ke oanter 'ran 15 1.331 < 0 . 01 o . 4 J. 0 I 0.226 I r 
Ep l n e 1)hrine 
1. " P 1 determine d by .:::, .L oup ana l y sis 
2 . ~x_t):eessed as we t vve i .)."lt 
1 
v s. 
drug 
alone 
0 .3 
< 0 . 01 
< o .~-
> 0 . 02 
Eff ect of rl locking Agen~s on the Calorigenic 
Action of Epinephrine in the I solated Rat 
Di aphragm . 
Interpr~tation of Results 
1. The Effect of Epinephrine 
B~inephrine in a concentration of 1. 6 X 10-6 
mols caused a rise in the oxygen consumption of 0 .27 
ml./gm ./hr. This was equivalent to a rise of 24 .3% over 
the contro l value . This exper iment was designed, for the 
mo st part , as a paired data experi ment. However, it was 
noted that although there was a variability i n the re-
sponses between the halves of the same diaphragm, those 
diaphragms treated \vith epinephrine consistently used 
more oxygen than those without epinephrine. The possi-
bility that this effect was due to the s light acidit y of 
~ he epinephrine , was ruled out by preparing a soluL.ion 
of diluting f l uid alone , vdth as much acid added to it 
as was added to the ep i nephrine . The experiment was also 
controlled so that those diaphragms receiving epinephrine 
were not always prepared in the same position, i.e., con-
trol and experimental tissues were prepared alternately. 
As many factors as could be thought of v..rere controlled so 
that this increase in the oxygen consumption due to epi-
nephrine is believed to be a _ specific effect . A series of 
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experiments was performed to det~rmin e the R. Q. of the re-
a ction, and since the R. Q. was al most 1.0 in every case , 
the i ncr ease i n oxygen conswnption is considered to be a 
reflection of the burning of glucose . 
2 . The Effect of SY-21 
It was noted that SY-21 i n a concentration of 
lo-5 Jvi di d not a lter the normal rate of oxygen consumption . 
~vnen epinephrine was added t o the medium, the mean oxygen 
consumption rose 0.10 ml. /gm ./hr. This represents a mean 
increase of 9 .0% over the rate with SY-21 alone . This 
difference was not significant. The tissue treated with 
SY-21 and epi nephrine used only l/3 as much oxygen over 
the controls as did the tissue treated with epinephrine 
alone . This difference was significant. Since no differ-
ence could be shown betvveen the oxygen consumption of the 
diaphragm treated with SY-21 and epinephrine m1d the un-
treated dia phragm, it may be concluded that SY-21 reduces 
the calorigenic effect of epinephrine in the isolated rat 
diaphragm to the point of complete blockade. 
3. The Effect of DH0-180 
This dihydrogenated ergocornine in a concen-
tration of lo-5 M exerted a significant calorigenic action 
on the isolated muscle. It raised the mean oxygen con--
sumption 13.8% above the control value s . This i nc reas e 
in oxygen consumption brought the value to almost that in 
response to epinephrine in the otherwise unt reated tissue. 
\'v'hen epinephrine vrds added to a DH0-180 treated diaphragm, 
the mean oxygen consumption was raised an additional 13.6% 
to produce a significant increase over the rate with the 
DH0-180 alone. The rate, however, did not si gnificantly 
exceed that of the epinephrine alone despite the calori-
genic activity of DH0 -180 alone. This means that with 
respect to the total increase in oxygen consumption re -
sulting from epinephrine, there was a partial reduction 
produced, i.e., from a mean 24 .3% increas e to a mean 
13.6% increase. However, a complete inhibition , obvious-
ly, did not occur. 
4 . The Effe ct of Neoantergan 
This antihistamine, in a concentration of 10-4 l i 
did not signi ficantly alter the rate of oxygen consumption 
of the isolated muscle. Vlhen epinephrine was added to 
the Neoan.tergan treated diaphragm, the oxygen consumption 
increased 14.7%. Here again there is the suggestion of 
a partial reduction in the calori genic effect, ie., from 
24 .3% to 14.7%, but no suggestion of a complete blockade . 
Summary - SY-21 (10-5 M) cornplete 'y blocked the epinephrine-
induced calorigenic effect in the isolated muscle . There 
i s a suggestion that DH0-180 ( l0- 5 M), itself slightly 
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calorigenic, produced a pq.rtia l blockade, but the blocking 
inf l uence of this compound on the oxygen consumption of 
the diaphragm is not believed to contribute considerably 
to the reduction of oxygen consumption in t.he intact 
animal. This opinion is offered in view of the obser-
vation that the oxygen consumption of the diaphragm treated 
with DH0-180 and epinephrine was ·not different from that 
of the tissue treated with epinephrine alone . Similarly, 
the results with Neoantergan (10-4M) suggested that t his 
drug produced a slight reduction in oxygen consumption in 
epinephrine-treated diaphragms. 
• 
Treatment 
Control 
Effect of Grade':l Doses of Epinephrine on 
Glycogen Synthesis of the Isolated Rat 
Diaphragm During . Two Hours of Incubation 
# of 3Glycogen pl pl 
Expts value after vs. vs. Epi . 
2 hrs . control 1.6 
I '1 X 10- 7M mg;gm"-
10 3 .47 
I_ 0.30 
Epinephrine 5 
1.6 
3 .40 i. 0.24 )0.05 
X l0-7Ivi 
Epinephrine 9 4 . 24 1:. 0.27 
(O.Ol 
l. 6 6 
X 10- M 
Ep inephrine 5 4.24 ( 0.01 1:. 0.25 1 . 6 
x lo-5Ivi 
1 - ''p " - group analysis 
2 - 1 et weight of tissue 
3 - Expressed as glucose 
<' 0. 01 
< 0.01 
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pl 
vs. ~pi. 
1.6 I' 
X 10-0 M 
)0 . 5 
Effect of Graded Doses of Epinephrine on 
Glycogen Synthesis of the Isolated Rat 
Diaphr~gm During Two Hours of Incubation. 
Interpretation of Results 
The influence of graded doses of epinephrine 
on the alteration in glycogen after two hours incubation 
paralleled the influence of graded doses of epinephrine on 
oxygen utilization . That is, 1.6 X lo-7 M was without 
effect and a ten-fold increase showed a significant effect. 
A hundred-fold increase caused no greater effect than a 
ten-fold increase. 
The apparent discrepancy, i.e., more glycogen 
with epinephrine than without it is believed to be a 
time factor and is discussed under the section dealing 
with "Effect of epinephrine on glycogen synthesis in the 
rat diaphragm". 
The data concerning the effect on glycogen to-
gether with the effect on oxygen utilization were re-
sponsible for the final decision to use epinephrine in a 
concentration of 1 . 6 X 10-6 M. 
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The Effec t of' Blo.cking Agents of Epinephrine ..-
Induced Effects on Glycogen Synthesis in the 
Isolated Rat Diaphragm. 
Interpretation of Results 
l) Ef fe ct of Epinephrine 
/ 
A concentration of eninelJhrine of 1. 6 .i_ 10-o lJI 
.L I. 
caused a mean reduction i n the total glyco gen value of 
24 . 8%. This was a true reduction . It i s int eresting to 
note that there ~ovas a mean increase i n oxygen consumption 
of 24.3 7~ -v;hi ch, since the R. Q. was 1.0, presumably was 
used to burn glucose. This leads to the speculat ion that 
the glucose which would have gone to glycogen vms oxidized 
i nstead , under the influence of epi nephrine. It is not 
poss ible to tell whether this reduction i n total glycogen 
after one hour , represents a decrease in glycogen synthesis 
or a splitting of glycogen already formed . 
It was noted that i f incub ation were a llowed to 
cont i nue for an additional hour, i.e. for tvm hours, that 
there was a peculiar shift in the glycogen s ynthes is 
v a lues. The control value f or glycogen changed from a 
value after one hour of 5 .13 + 0 .17 mg . /gm., to one of 
3 .47 ± 0 .3 0 after two hours of incubation. On th e other 
hand , t he gl ycogen value of diaphragms treated with 
1 . 6 x 10-6 l'l of e pinephrine s h i f ted from a g1ycogen va lue 
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of 3.86 l 0.31 mg . /gm. after one hour, to 4 . 24 i 0 . 27 after 
two hours of incubation. Thus, after two hours of incu-
bation, there is apparently a reversal of the effect of 
epinephrine. It is possible to explain this discrepancy 
by the hypothesis previously offered that the eff ect of 
epinephrine starts to wear off after one hour of incu-
bation. The mass of hexosemonophosphate which had been 
accumulated during the first hour ( 1/3 of the glucose taken 
up may have been in this form) is now available for oxi-
dation. Therefore, it becomes the precursor for glycolysis 
instead of muscle glycogen. The glucose which is taken up 
during this second hour of incubation , is now probably con-
verted to musc l e glycogen . The control diaphragms , hmvever, 
continue to call upon their glycogen reserves for glycolysis. 
A similar situa tion was observed by Cohen (22) who noted 
that the muscle glycogen of the epinephrine- treated diaphra~ns 
did not decrease as did the glycogen of the untreated dia-
phragms during incubation. 
2) Effect of SY-21 
A concentration of l0- 5 M of SY-21 itself reduced 
the total mean glycogen value of the isolated diaphragm 
after incubation 8 . 0%. This reduction did not reach the 
level of the reduction produced by epinephrine. When epi-
nephrine was added to a diaphragm pretreated with SY-21, 
there was a gain a mean reduction of 8. 2% of the untreated 
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diaphragm bringing the total glycogen level almost exactly 
to that with .SY-21 alone, which left it still hi gher than 
that with epinephrine alone. It may be concluded that al-
though SY-21 itself caused a decrtjas in glycogen synthesis, 
it completely blocked the effect of epinephrine in this 
response . 
3) Effect of DH0-180 
DH0-180 in a concentration of lo-5 M produced a 
mean reduction in the total glycogen value of 8. 6% of the -
control value. It should be recalled that a mean increase 
of 12. 6~; in the oxygen consum ~', tion was also produced. 'rhis 
decrease in glycogen synthesis was not as l ow as that pro -
duced by epinephri ne . Wh en epinephrine was added to the 
DH0 - 180 treat ed diaphragm, an additional reduction of 
21.8% in the mean glycogen value occurred. This approaches 
the reduction of 24.8% seen with epinephrine alone. Al-
though the final mean total value for the glycogen fo llov.r-
ing DH0-180 and e pinephrine is 4-9% less than that with 
epinephrine a lone , this decrease is not s~atistically 
significant. It may be concluded tha"G the epinephrine 
factor L1 glycogen synthesis Has not influenced by 
DH0 -180 in the isolaL.ed muscle . 
4) Effect of rJeoantergan 
Neoantergan in a concentrar.ion of lo-4 M reduced 
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the mean total glycogen vaJ_ue 10 . 27~ of the con·cro l value 
which was Do t as lovr a s that produced by epinephrine . 
The addi tion of epinephri ne to a diaphragm pretreated 
with t he anti hi s t ami nic caused an additional mean re -
duction of 26 .. 7~& . Thi s should be compared with the 
reduction of 24 . 87; due to ep i nephri ne in an otherwi se 
untreated diaphragm. Th e combi ned effect of a 10. 2% 
reduction due to Neoantergan and the 26 . 7~~ reduction due 
to t he addit ion of e pinephrine, brought t he final glycogen 
value below that f ound vvith epinephrine in an other1-vise 
untreated diaphragm. Thus, it may b e concluded that 
Neoantergan doe s not r educe the epinephrine factor in 
glycogen s-y-nthesis, and may actually potentia te it. 
3umrnary 
Ii:pinephrine caused a reduction i n glycogen 
synthesis. SY- 21 (lo-5 h ) blocked the epinephrine i n -
du ced eff ect on glycogen synthesis, although it it. self 
reduced the glycogen synthes i s . DH0-180 and Neoant e rgan 
themselves reduced the rate of s ynthesis and did not 
influence the action of epinephrine . 
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'l'he .t!;f'fect of Var_ious Blocking AgenJGs on 
~pinephrine-Induced Calori genic Effe ct on 
the Isolat ed Rat Liver Slice . 
1) The Effect of ~inephrine 
Li ke the effe ct in the iso lated muscle prepa-
rat i on, ep inephrine ( 1. 6 ~ 10-6 t.I) si gnificantly inc:ceased 
the oxygen consumption of the l iver slice . This increase 
was 22 .4% over the control value . 
2) The ~ffect of ilH0 - 180 
This derivative of erg ocor-ni ne did not s i gnifi-
cantly alt er the resting oxygen consumption of the liver 
slice. It was found to completely block the epinephrine-
induced increase in oxygen utilization. 
3) The Ef f ect of SY-21 
'rhis 2- halogenated ethylamine , used in the same 
con centration as was used i n the isolated muscle preparation, 
showed a s i gni f icant blockade of the epinephrine-induced 
calorigenic effect on the liver s lice . Actually , however, 
this should be considered a reduct ion in the response rather 
than a blockade . It will be noticed f r om the statistics 
that tL e drug alone did not si gnifi cantly increase the r est -
i ng oxygen consumption . dhen ep inephrine was added to the 
SY- 21 treated diaphra gm , the oxygen' consumpt i on rose 12 . 77~ 
above that of the control_ rate. Although thi s was not 
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significantly different from the ra-ce v.ri th SY-21 alone, it 
is significantly greater than the rate v.ri thout any arug 
added . 
In order to test if this effect might be due to 
the halo genated et hylamine grouping, SY-73, an hydroxy-
lated ethylamine was tested . This a gent is without 
adrenergic blocking activity in the intact animal and did 
not block the epinephrine-calorigenic effect on isolated 
l iver. 
4) Neo8.nter~gan 
Neoa11tergan vms tested in a concentration of 
lo-4 M, the same concentration as was used in isolated 
muscle studies . It was without any appreciable effe ct on 
the calorigenic action of epinephrine . This concentration 
was the same as would exist i n the animal if 3 mg ./kg . were 
injected and all of it v-rere evenly distributed throughout 
the blood . In order to see the effect of a larger concen-
tration, 2 .f.. lo-4 Jl'l was added to the preparation , and again, 
"chere vvas no effect on the increase in oxygen conswnption 
following epinephrine. 
Surnmar:z 
Epinephrine (1. 6 X 10-6 W) caused an increase in 
the oxygen utilization of isolated rat liver slices. DH0-180 
completely blocked the effect of epinephrine. .3Y -21 
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significantly reduced t he . response t oe inephri ne but did 
no·c completely block it. SY-73, not an adrenergic block-
i ng drug , but an agent with the et hylamine grouping was 
without effect. Neoant ergan was without eff ect even in 
doses l arger than that vvhich vmuld usuc.:tlly be i n j E:!cted 
into the i ntact t:l..nimal. 
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The :.!;ffect of V.arious Blocking Agents on 
Epinephrine-Induced Glycogenolysis in 
the Isolated Liver Slice of the Rat. 
l) Ef f ect of Epinephrine 
Epinephrine (1. 6 ~ lo-6 M) reduc ed the liver 
glycogen by 4Lh 9% of the cont:.rol value after one hour . 
2 ) Effect of DH0-180 
DH0-180 complet e ly blocked the glycogm10lytic 
eff ect of epi nephr ine on the iso.lated rat liver. It should 
be noted that this compound was without effect on the i so-
l ated muscle preparat ion. The se data suggest t hat DH0-180 
i s selective i n its action on the liver. From this , one 
may infer that the blockade of epinephri ne-induced hyper-
glycemia in the inta ct rabbit , 1-'l]ith this agent , is due to 
its effect of preventing liver glyco genolysis due to epi-
ne phrine . Thi~ logically would result in a complete 
blockade of the hyperglycemia such as was seen i n rabbits . 
Even though the e f fe ct of epinephrine in mus cle was present, 
the only way i t could contribute to the hyperglycemia was 
t o send lactic acid to the liver for glyco genesis . However , 
a t t h e liver t he glycogenolysis of this new glycogen , even 
if it were f ormed wo uld be blocked by DH0-180. 
3) Effect of SY- 21 
SY- 21 i n a concent ration of lo-5 I·l caused a 
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s i gnificant reduction in the glycogeno lys is due to epi-
ne phrine. oY-73, an et hylw;1ine compound wit hout adrener gic 
blocking a ctivity i n the intact animal, was wit hout e f f ect. 
In view of the combined results of the effects of SY- 21 in 
liver and muscle , it is suggested t hat the primary a ction 
of SY- 21 is on the muscle. Some glycogenolysis is still 
present fo llowi ng ep inephrine in its action on the liver . 
This may expluin why SY- 21 succeeded in only reducing the 
e pi nephri ne-induced hyper glycemia in rabbits and dogs and 
no t compl et e ly blocki ng the response a;:, did DH0-180 i n 
rabbit s . The primary cause of th e epinephrine-induced 
hyperglycemia is probably its effect on the liver. The 
effect on musc l e pr obab ly only s erves to sustain the 
ef fe ct. If a given agent blocks ~he effect of epinephrine 
on t he muscle but only reduces the effect on the liver , 
i t is logical that it will only reduce t he hyperglycemia 
c.:md nqt completely block it. 
4) Eff ect of Neoantergan 
Thi s ant ihistamine , in a dose of lo-4 M and 
t he latter being a very hi gh concentration , 
was without effect on the liver glycogenolysis due to 
e pi nephrine. 
Summary 
Epinephrine cau~es a glycog~nolysis of the 
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isolated liver slice. This effect is blocked by DH0 -180, 
indic <::t ting that there j_s a selective action for DH0 -180 
on the liver in this response. It is suggested that it 
is through its action on the liver that this agent causes 
complete blockade of e pinephrine-induced hyperglycemia in 
the intact rabbit. SY-21 succeeded in reducing the re-
s ponse of e pinephrine. This suggests that the complete 
blockade i n muscle in addition to the reduction of the 
effect in liver is reponsible for the reduction rather 
than the complete blockade of' epinephrine-induced hyper-
glycemi a i n the intact rabbit and dog . SY-73, an agent 
without adrenergic blocking a ction vras without, effect in 
this response . Neoant ergan, an antihistaminic effective 
in reducing the hyperglycemia of int,act rabbits, was \'lith-
out effect on the isolated rat tissues even i n large doses. 
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DISCUoSION 
In the isolated diaphragm , the experiments 
deali ng with the effect of graded doses of epinephrine 
i ndicate that a maxi mum effect is achieved ·with a dose 
of e pinephrine corresponding to a concentration of 
l . 6 X lo-6 Iv.i . This concentration i s the same as that 
found to p roduce maximum gl ycolysis of the isolated 
liver slices by other worker;:; {116) . 
Under the condition;:; of this experiment, where 
200 mg . % of glucose was supplied to the diaphragm of an 
unfasted rat at the beginning of the experi ment there 
was an increase in the rate of oxygen utilization during 
the first hour of incubation \vi th epinephrine . This 
increased rate was apparently due to an a ccelerated 
burning of the carbohydrate, since the R. Q. was 1.0. 
During the second hour of incubation, the rate of oxygen 
utilization was still elevated in the epinephrine-treated 
diaphragms, but the elevation was less than during the 
first hour . A clue to the mechanism of this decreased 
rate \vas supplied by the R. Q. 1tihich rose to a figure 
above 1 . 0 during the second hour period , indicating 
storage of fat and/or protein. In such an instance, 
oxygen would become available from the raetabolic con-
version of glucose to fat or protein, and would be 
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ut i liz ed for further oxidat ions . External measurements 
would , therefore , indicate a decreased rate of o:h.rygen 
consumption, although the tissue may be respiring at t he 
same rate . Although the convers i on of carbohydrate to 
fat is usually thought of as occurring in the liver , 
Chernick et al . (20a) hav e shown that the isolated rat 
diaphragm is also capable of converting cl4-labeled 
glucose to fatty acids . 
Epinephrine also caused a decrease in glycogen 
synthesis during the first hour of incubation . In the 
presence of glucose in the medium , sucn as t here was in 
these experiments , th i s mi ght be due to a de creaded 
convers i on of glucose to glycogen , or an increased 
glyco geno l ysis . The studies of 1,uerkischer and 
~ertheimer (117) demonst r a ted that the i n crease in 
glycogenolysi s wi th epinephrine , in t he absence of 
gluco s e in the medium, was almost t he s ame as the de-
crease in glycogen synthesis with glucose i n the medium. 
·J:'h er efore , it is likely Lhat at l east part of the apparent 
decrease i n glyco gen synthesis vms a reflection of an in-
crea s e in glycogenolysis . 
Sutherland ( 115) , in a re cent revie'l-v of his 
stud ies on the influenc e of epinephrine in phospho r yl as e 
systems i n l iver and muscle , has directed attention to 
evidence t hat ep i nephrine exerts its prime effect on the · 
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phosphorylase of the tissues. The amount of active phos-
phorylase found i n tissues repre sents u balance between 
inactivat i on and resynthesis of phosphorylase. Suther-
l and and Cori ( 116 ), Walaa s and Vlal aas (121), and Elli s , 
Anderson and Turtle ( 37), have demonstrated t hat the 
amount of a ctive phosphoryl ase in is.olated liver and 
musc le tissue treated with epinephrine is markedly in-
creased . It \va s suggested , in view of the fact that 
e pi nephrine does not inhi b it e nzymatic in!:l.ctivation of 
phosphorylas e as does fluoride that i ts mechanism of 
action was to actually promote t he synthesis of thi s 
enzyme . 
The further i nteresting fact is that the 
direct ion of the phosphorylase a ctivity is apparently 
r eversed , i . e ., the reaction proceeds mainly in the 
d i rection of glycogen breakdmvn . That the addition of 
e :)i nephrine to isolated muscle and liver results in a 
glycogen depletion is too v"lell known to vvarrant documen-
tation. Hegnauer and Cori (64) clearly demonstrated 
that the i ncreased glycogen brea kdown in fro g muscle 
incubated anaerobically with epinephrine was accompanied 
by an accumulation of hexosephosphate and a corr esponding 
decrease i n i norganic phosphate. Riesser (100) and the 
Walaases (121) also showed tha t there was this apparent 
reversal in direct ion of phosphorylase eff ect i n i solated 
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~at diaphragms . The experiments reported herein do not 
conc lus i ve l y demonstrat e an increased glyco~enolysis 
in the presence of glucot:ie i n t he medium, but they do 
show that under these conditions , epine hrine caus ed a 
decreas e in glycogen s ynthesis . This , coupled with a 
decrease i n the mnount of glucose accounted f or, s uggests 
t hat c;p in8phr ine caused an accumulation of intermedict·ces 
other t han glycogen in these experiments . The postulate 
that the direction of phos phoryla s e a ctivity i s reversed 
when the tissue is under t he influence of e pinephrine , 
together 1t1ri t h t he results of 'l'ue r kis che r and ~lert heimer 
(117 ) wou l d indi cate that glyco genolysis contributed to 
part of t.hese i nt ermediates . 
Thu s , eviden ce has b een pr esented by other 
workers that vhere i s an accumulati on of hexosemonophosphate 
f oll owing epinephr i ne admini stration to an i solat ed muscle . 
If one postulates that the a ction of epinephrine begins 
to wear off during the second hour, t he dianhragm , during 
t his eriod , -vwul d have a substc.:mt ial amount of hexo s emono -
pho s phate available fo r oxidation , whil e t- he m1tn~ate d 
dia?hrap;m would stil l need to call u:Jon its reserve of 
glyco ~ en . Thus, during t he sec ond hour period, t he con-
tro l di aphragms vmuld be us i ng glyco gen at a faster rate 
than the e pine ' hri ne -treated ti ssues and would account for 
r eversal i n the glyco gen pa t tern . Further evidence 
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pointing to this postulate of a lessening of ~he action 
of epinephrine during the second hour is afforded by the 
R. Q. during this period. Whereas the H.Q. of the control 
tissues rose to 1.07, that of the epinephrine treated dia -
phragm rose to only 1 . 04 . A release of the stored hexose-
phosphate would require additional amounts of oxygen for 
oxidation, and hence would still be using larger amounts 
of oxygen than the control tissue even though fat storage 
were occurring, resulting in a lower R. Q. than the con-
trols. 
We have succeeded in this experiment in account-
ing for only 2/3 of the glucose removed from the medium 
by the diaphragm treated with epinephrine in terms of 
glycogen and oxidized glucose. These findings indicate 
that the remainder of the glucose is in the form of one 
or more intermediate products. 
Epinephrine was found to induce a sli ght but 
si gnificant rise in glucose uptake by the isolated dia-
phragm . It is not known hmv important this i ncrease is 
to the entire animal organism. At first glance it seems 
surprising that the epinephrine should increase the uptake 
of glucose at the same time as it decreases the total amount 
of glucose utilization. However , further examination re-
veals that although the total amount of glucose utilized 
is decreased , the amount of glucose oxidized is i n creased, 
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and the decreas ed utilizat i on is at the expense of 
g lycogen formation. This effect i s, actual ly , a process 
which makes more ene~gy available to the tissue . Teleo-
logically, vle may consider this action of epinephrine 
on the muscle during conditions of stress as one \vhich 
not only increases the total energy output, but al~o in-
creases carbohydrate reserve of the tissue in case the 
supply of carbohydrate should for some reason be de-
creased. 
Tlalaas and Ualaas ( 121), performed an experiment 
very s imilar to the one reported here Hith epinephrine 
and rat diaphragms. For an unknmvn reason the results 
~<vith oxygen consumption and glucose uptake conflict with 
our own results . It was noted in our experiments that 
the oxygen consumpt i on and the glucose uptake increased 
in every case when the diaphragms were incubated with 
e pinephrine. However, in the -valaases' experiment there 
was noted a decrease in the gluco se uptake and no change 
in oxygen consumption . However , these vvorkers also found 
that there vvas less glucose accounted for in the epi-
nephrine-treated diaphragms than in the controls. One 
wonders if the difference in results could not be 
a'ctr ibuted to the time spent before incuba'cion amounting 
to l/2 to 3/4 of an hour and the difference in measure-
ment of initial values . Their initial values -v-vere taken 
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before equilibration started. In our own experiments the 
initial values were taken just after equilibration and 
before i ncubation. 
In the liver , it was not ed that e pinephrine also 
exerted t his ca l origenic action of about the same magnitude 
as was found in muscle. The classic ,~;lycogeiiolytic action 
of epinephrine on the liver was also quite evident. 
In addition to the report of Von Euler (3 8) who 
found that ergotamine blocked th~ calorigenic eff ect of 
epi nephrine on minced frog muscle , there have been some 
reports on the effect of adrenergic blocking drugs in 
reducing the increase in oxygen consumption ~<vhen epi-
nephrine was administered in vivo. Cappo (16) and 
Ore stano (97) obtained negative or doubtful results with 
ergotamine in the intact man and rat. On the other hand, 
Harangezo -Oroszy (59) demonstrated positive results in 
the anesthetized rat. Lundholm, in 1949 (82), gave epi-
nephrine in the dose of 20 gamma/kg. subcutaneously to 
cats and blocked the calori genic effect with ergotamine, 
in a dose of 20 gamma/kg. intramuscularly, which did not 
itself lower the oxygen utilization. In a later '•rork (81) 
he found that 200 gamma/kg . of ergotamine intramuscularly 
was necessary to block the effect of 20 gamma/kg . of nor-
e pi nephrine. That dose of ergotamine , however , produced 
a decrease in oxygen consumption. He concluded from his 
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experi ment that since the. dose of ergo t ami ne which blo cked 
epinephrine did not lower oxygen consumpt i on in the ab -
sence of epinephri ne , and doses of ergotami n e which bloc ked 
nor-epinephrine did , tha t nor- epi nephri n e is a ctua lly the 
sympat het ic mediator . His conclusion is r athe r queer 
since he tested only 2 doses of ergotamine , 20 ~amma and 
200 ga mma/kg . 
De Vlees chhouwer (120 ) showed that Di benami ne , 
SY- 28 Mnd SY-30 l ~ll all block the calori ~enic act i on of 
e pi nephrine und no r-epinephri ne in dogs which are a nes-
t hetized . No do ses uf b locking drugs wer~ report.ed . 
Issekutz , a German ( 70 ), has shmvn . that DH0 - 180 
a11d DHE- .45 are without effect i n reducing the calorigenic 
action of e pinephr i ne i n anesthetized rats . 
The only report found dealing with t he effect of 
a halot:..lkyl amine in vitro \vas that of Harvey , Hang and 
Nickerso n ( 61) \vho studied t h e effect of a 2- haloalkylcvn ine , 
SKF 688A , on mouse liver homo genates treat ed v·li t h epi-
nephri ne . The g l yco eno lys i s and glucose production vvere 
measured and it was found that the i ncrease in these 
effects produced by epinephrine was b l ocked by graded 
do se s of t h e blockin.; drug ranging f rom 10- 40 garm~a/ml. 
The de gr ee of blockade was pro portional to tle dose used. 
In the ?reviuus se ct i on of t h is t l esis , it has 
been s u~gestcd , in view of t he data obtained , that the 
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influence of adrenergic blocking and ant i histcunine drugs 
on epinephrine-induced ei'fects on carbohydrate metabolism 
may vary from species to spec i es . Therefore , the resul ts 
of experiments v·rith rc!.t tissues i n vitro should be con-
sidered as possibly being specific for the rat . It is 
also necessary to emphasize that conditions in vitro only 
simulate , and by no means exact ly reproduc e , t he con-
ditions in vivo . The writer is aware of the dangers i n 
explaining results in vivo by observations .1ade iri vitro. 
Evt:m more dangerous is an explanation of the results ~vi th 
one species obtained in vivo vvith the observations made 
with anot her species i n vi tro. However, the results ob-
tai ned wi th the isolat ed tissues of the rat make it 
possible to speculate on the various fact ors producing 
the results found in the intact rabbit and dog . There-
fore, the follov.ring discussion of mechanisms should be 
regarded only u.s speculative, and not as factual ex-
planations . 
The i nfluence of SY- 21 on these responses to 
epinephrine suggests an explanation for the eff ect of 
this agent on epinephri ne - induced hyperglycemia in rabbits 
and dogs . It will be remembered that SY- 21 , although a 
potent adrenergi c blocking agent , even in a dose of 2mg . / 
kg . succeeded only in reducing the hyperglycemia of both 
rabbits and dogs . In the _i solated r at tissue, it was 
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notea that, whereas SY- 21 completely blocked the response 
in muscle, it only part i ally blocked the effect in liver 
tissue. 3ince the hyper glycemia produced by epinephrine 
is probably due primarily to the liver glycogenolysis, 
(the rnuscle effect s serving to sustain t 1e action by 
restor i ng liver glycogen from lactic ac id) a partial 
blockade of the liver proces ses \<Vould, logically, only 
result in a pa:ctial blockade of the hyperglycemia . Since 
SY-21 blocked the effects of epinephrine in i so l ated rat 
muscle, t he failure for this a gent to redu~e epinephrine-
induced lacticacidemia in dogs is still an open question. 
Although , species specificity should be considered; a 
circulatory factor should a lso be considered. Vv'i th a 
dose as large as 2 mg . /kg. of SY-21, the injection of 
epinephrine would result in a decrease in blood pressure, 
and probably in some resultant pool i n3 of b lood . This 
1·voula allow an ac cumulut ion of lactic a cid so that when 
measured, it would ap pear higher than normal . This l atter 
explanation would give some clue to the failure of the 
agents used in the dog to bloclc the lacticacidemia pro -
duc ed by e pinephrine injection. 
The first suppress ion of the glycogGnolytic 
effect of epinephrine in vitro was accomplished by Frolich 
and Pullack (43) and I'i1orita ( 89 ). 'l'hese workers succeeded 
in b locking the glyco gcmolytic effect of epinephrine in 
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ergotoxin perfused livers.. Houssay and Gersc.hman ( 67) 
successfully produced the blockade in a similar experiment 
using ergotamine and dihydroergotamine. Tuerkischer and 
Wertheimer (117) using incubated rat diaphragms produced 
a blockade of the glycogenolysis with ergotamine. How-
ever, Hegnauer and Cori (64 ) were unable to block the 
increase in lactic acid and hexosemonophosphate production 
in isolated frog muscle with ergotamine. In their experi-
ments, the muscles were incubated in a nitrogen atmosphere. 
Ellis, Anderson and Turtle (37) studied the 
effect of epinephrine on liver slices from rats and rabbits. 
It was found that there was a marked increase in glucose 
liberation and phosphorylase activity when the slices were 
incubated vlith epinephrine. Rabbit liver slices gave a 
larger increase in these reactions than the rat liver 
slices. It was found that dihydroergotamine blocked the 
effects of epinephrine in the liver. 
The action of dihydroergocornine, which gave a 
suggest ive reduction of the increase in oxygen utilization 
induced by epinephrine in the diaphragm, and a complete 
blockade of all the effects measured in the liver, gives a 
c l.ue to its mechanism of action in the intact rabbit and 
rat (3 6). If, again, t he primary cause for hyperglycemia 
in the intact animal as a result of e pinephrine injection 
was the outpouring of glucose from the l iver, then 
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blockade of the lysis Qf liver glycogen should result in 
a complete blockade of the hyperglycemia. Since the 
effect on muscle only sustains the hyperglycemia by 
replenishing glycogen from lactic acid , then this new 
glycogen is also blocked by DH0-180 and hence the blood 
sugar would still not become elevated. 
Neoantergan was fouhd to be an effective block -
ing agent of epinephrine-induced hyperglycemia in the 
rabbit, but in these experiments in the rat it 1.vas found 
to be without blocking a ctivity , _ even in high concen-
trations. Indeed, its action on isolated r uscle tissue 
i nd icated that it mi ght potentiate the effects of e pi-
nephrine by increasing the r ate of glycogenolysis and 
decreasing the rate of glucose uptake. These latter 
effects suggest some explanation for the action of some 
antihistamines to potentiate t he hyperglycemia in dogs. 
One is forced to conclude that the blocking action of 
this ant ihistaminic agent in the rabbit is due to some 
non-specific action or to some effect on carbohydrate 
metabolism ·which is rabbit specific. The action of 
Pitocin, Pitressin, and ephedrine to inhibit epinephrine-
i nduced hyperglycemia in the rabbit, suggests that the 
rabbit may be sensitive to agents which produce circulatory 
changes. The ability of several antihistamines to poten-
tiate the pressor effects of epinephrine, suggests that 
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i n the pr e sence of e 1)inep hrine these a gents a lso i nduce 
circulatory changes, vvhich mi ght have some e f f ect on 
carbohydrate metabolism in t he rabbit . Other such non-
s pecific I7lechanisms in vrhich ca rbohydrate met abolism is 
• 
only indirectly affe cted can be postulated, but t he proof 
for an y such mechunism is st i ll lack ing . 
Gt:N~HAL SUl'!~vlAHY AND CONCLUSIONS 
'.iJhen epinephrine is injected into an intact 
animal, one of the cha racteristic changes that ca n be 
obs~~rved is an hypergl ycemi a. There are t wo possibl e 
mechanisms by whi ch the blood sugar could be increased 
in the f asted animal . The first is an increase in the 
rate of liver ~lyco genolysis which releases glucose into 
the blood stream. The second is a decreased rate of 
g ucose uptake by the ti ssues which results in an a c-
cumulat i on of glucose in the blood st r eam . The action 
of e p ine phrine ha s been postulated to be on both of 
these mechanisms. 
It ha s been suggested th··l.t t he pro cess referred 
to in the literature as glucose utilization should be 
considered as two s eparate pro cesses . The first h<:lS been 
termed "g lucose uptake" , and was def ined as t he process 
of removal of glucose from the blood stream by the 
tissues and the phosphorylation of this gl uc ose. The 
second pro cess ha s been termed "glucose utilizationn, 
a nd was defined as the conversion of phosphorylated 
glucose to glyco gen , carbon dioxide, water , and lactic 
a cid . The basis for t h i s suggested separat i on was the 
find ing that these two processes, gluco~e upt ake and 
g lucose uti l ization , were capable of varying independently 
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of each other in vitro. 
In the intact urgani~m , it is difficult to 
measure thc;se tvw proces ses independently, and the 
method used has be~n to measure the A-V differences in 
blood glucose. By the standards set in the above defi -
nitions this is a measure of glucose uptake. It. may be 
called glucose utilization only by assuming that the 
glucose utilization, as defined above , va:r·ies directly 
with the glucose uptake. This assumption is felt to be 
false i n view of the observation reported herein that, 
at least in the presence of epinephrine, the glucose 
utilization of the isolated rat diaphragm may vary 
inde pendently from the g lucose uptake. In addition, 
it has been pointed out in the literature (32) that 
the methods for d termining the blood glucose concen-
tration are of such a low order of accuracy, that the 
error in determination alone may be sufficient to shovv 
the A- V differences to go up, down or stay the same. 
It is believed that this factor may explain the di-
vergent views expre::;sed in the literature regarding 
the action of epinephrine on glucose uptake in vivo. 
Furt,hermore , part of the effect seen in vivo may be 
due to the action of insulin and adrenocortical hormones . 
The observations reported herein, on the in-
fluence of epinephrine on the isolated rat diaptragm 
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demon strat ed t h at the rate of glu cose uptake increased 
slightly but sig;nificantly. In addition , the rate of 
glucose utilizat i on decreased . It has been shown t hat 
this decrease in glucose utili za0ion by the isolated 
muscle was at the expense of glycogen synthesis . There -
fore , despite the decrease in overall glucose utili-
zat i on , t h ere was still ~n increa~e in the amount of 
glucose oxidized . The isolated rat diaphragm exhibit ed 
an R. Q. of 1 . 0 during the first. hour of fncubat ion \'lith 
epinephrine . During the second hour, the a. Q. was 
f'ound to rise above l. 0 and 1-vas taken to indicate the 
conversion o f carbohydr <:.tte to fat . The iso l a'ced rat 
d i aphragm has previously been observed to convert 
carbohydrate to fat (20a) . 
If the author can be permitted to speculate 
on an explanation for the responses in intact ani mals 
by the observations made in isolated tissue prepErations, 
it may be said that the primary or early eff ect of in-
jected epi nephrine is a n induced hyperglycemia by means 
of <.:Ln increased liver glycogenolys is. This increased 
blood glucose is pic .ked up by the musc l es at an increased 
rate . Once the glucose is phosphoryl ated by the muscles , 
less is converted to glyco gen then would be i f the hyper-
g lycemi a was due to other reasons than ep i nephrine in-
jection. On the other hand, there is an increase in 
l2p 
g lycoly::>is as a result of epirwph:l.''ine injection causing 
a lacticacidemia. This increase i n glycolysi s is not 
sufficient to balance the decrease in glycogen synthesis 
and ""che result is a s""corage of in·c armediate ; probably 
hexosernonophosphate . imphasis should be placed on the 
statement that these suggested mechanisms in the intact 
animal are the primary or early effects of epinephrine . 
I n the i ntact animal , the presen ce of a hyperglycemia 
would result in a secretion of insulin. Therefore, the 
later res ponses following epinephrine injection would 
be t he result of the combined actions of e pinephri ne , 
insulin, a nd adrenocortical hormone . 
A number of adrenergi c blocking drugs belong-
ing to a St:Jries of ethly homologues of Aryl- 2- halo-
alkylarnines have been synthesized recently vrh ich are 
capable of inhibiting most of the excitatory effects of 
epinephrine . The data reported herein, demonstrated 
that most of these drug s were effect ive in inhibiting 
t he hyperglycemic action of epinephri ne in the rabbit. 
Furthermore , it 1as been suggested that the effective-
ness of these agents, at least in the rabbit, roughly 
paralle ls their potency as i nhibitors of other excitatory 
effects of epinephrine . If the structures of some of 
t h e more potent adrenergi c blocking drugs are changed, 
by replacing the halogen wi-th an hydroxyl group , or by 
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converting the ethyl homologue to a methyl homologue, 
the resulting compounds lose or have a reduced adrenergic 
blocking activity . Such compounds were also unable to 
block epinephrine-induced hyperglycemia. 
When these agents were injected into dogs, the 
hyperglycemia induced by an infusion of e pinephrine was 
reduced. However , they failed to reduce the lactic-
acidemia induced by epinephrine. In view of the finding 
that one of these agents, SY-2l,reduced the glycolysis 
induced by epinephrine in the isolated rat diaphragm, 
at the risk of transferring from in vitro experiments 
with one species to in vivo experiments of another, it is 
suggested that the failure to reduce lacticacidemia in 
the dog was not due to a failure to inhibit muscle 
glycolysis. It has been suggested that the lacticacidemia 
following SY-21 and epinephrine is due t o a circulatory 
accumulation of lactic acid. I n the presence of an 
adrenergic blocking drug in the dose used (2 mg . of SY-21 
per kg .) e pinephrine causes a decrease in blood pressure, 
and presumably a pooling of blood. Under such conditions, 
although the actual amount of lactic acid entering the 
blood stream might be decreased, it vvould not be carried 
to the liver as fast as it would if the blocking drug 
were not present . Therefore, measurement of a given 
ali ouot of blood would show a lacticacidemia that was not 
~ 
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. due to muscle glycolysis . 
~Y-2 1 was found to completely inhibit all of 
t he eff ects of epinephri ne on carbo hydrat e metabolism 
wh ich were measured in the i solated rat diaphragm. On 
the other he:md it only parti al l y i nhibited the glyco -
genolysis induced i n t he isolated rat liver slice by 
epinephrine. Hence , s inc e the pri mary action of epi-
nephrine in producing an hyperglyc emia i s to i nduce 
liver glycogenolys i s , one would expect to find only a 
partial reduction of epi nephrine-induced hyperglycemi a 
1.-.rith SY- 21. Thi s was found to be the case in both the 
rabbit and the dog. 
Di hydroergo corni ne was found to block epi -
nephrine-induced hyperglycemia in the r abbit, but was 
without effect i n the dog . lhe r eason for this failure 
in the dog i s be lieved to be i nsuff ici ent dosage . Dogs 
v1ere unable t o tolerate doses higher than 0 . 05 mg ./kg . 
v-1j.t hout retchi ng and vomit i ng . In t he studies on the 
surviving tissues of t he rat, it was found that DH0-180 
produced a COQpl et e i nhibition of liver glycog~nolysis 
induced by epinephrine , but only a suggestion of in-
hibiti on of the effects of epinephri ne on carbohydrate 
metabolism i n the di aphragm. Furthermore, DH0 -180 , 
i t self , reduced the glycogen synthesis and increased 
the oxygen uptake of the ·diaphragm, so that its effect 
12_9 
sumoed wi th the reduced _eff ect of epine phri ne to give 
final values similar to that roduced by epinephrine 
in an oLherwise untreated diaphragm . Be cause of the 
complete i nhi bition s een in t he isolat ed liver studies, 
it i s not surprising t hat DH0-180 produced a complete 
suppression of hyperglycemia i n the intact rabbit . 
Si nc e sever al antihistamines can infi ue n ce the 
pressor effects of e pinephrine (76, 77), several of 
these agents were tested for their ability to influence 
epinephr·i ne-induced hyperglycemia in the rabbit. The 
ability of these agents to inhibit the rise in blood 
sugar due to epinephrine in the rabbit paralleled their 
ability to inhibit the action of histamine on the bronch-
ioles and intestine of the guinea pig. Since large doses 
of aminophylline did not reduce the hyperglycemiB., it 
is suggested that the effectiveness of some of these 
a gents was not re lated to their ethylenediamine structure. 
Th e effectivensss of some of t hese agent s does not appear 
to b e r elated t o t heir atro pine-l i ke or lo6al anesthetic 
properties since atropine, cocaine, and pr ocaine were un-
able to i nh i bit epinephri ne-i r0uced hyperglycemia . On the 
other hand , Pitressin, Pitocin, a nd ephedrine did reduce 
the rise i n blood sugar induced by epinephrine. In vie-v; of 
this , it is suggested that the antihistamines, in the 
presenc e of epinephrine , perhaps act through some circulatory 
130 
changes which influence carbohydrate metabolism only in-
directly . 
In dogs , of three antihistamines test ed only 
Chlorothen reduced epinephri ne-induced hyperglycemia, 
but d id not influence the lacticacidemia. On the other 
hand, Histadyl and Chlortrimeton, \ihich blocked the 
blood sugar rise in the rabbit, potentiated the hyper-
glycemia i n the do g . Furthermore, Neoantergan , one of 
t he most potent i nhibitors of epi nephrine-induced 
hyperglycemia in the rabbit, did not i nfluence the 
effects of e pinephrine on carbohydrate metabo lism i n 
the isolated rat liver and di aphragm . These obser-
vations together with those reported in the literature 
suggest that the ability of the antihistamines to i n-
hi bit e pineph.cine-induced hyperglycemia i n the rabbit 
is species specific. 
It is conclude'd that it is a general property 
of th0 more potent adrenergic b locking drugs to inhib it 
er i nephri ne-induced hyperglycemia in s evero.l mammalian 
species . This property exists both in vivo and in vitro . 
-- ---
Since t:,hese agents by themselves do not cause hypo-
g lycemia in vivo or reduce glycogenolysis or glycolysis 
in vitro , it is suggested that their mechanism of action 
is to block the effect of epinephrine rather than i n -
fluen cing carbohydrate metabolism di rectly . Therefore, 
131 
these a gents make convenient research tools for the 
study of carb ohydrate metabolism . Through their use, 
it is possible to study the influence of a variety of 
substances on carbohydrate metabolism ~ithout the 
complicat ing presence of epinephrine influences. 
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Abstract 
Under conditions of general body s tress, the 
adrenal me dulla is called upon to secrete its hormone, 
eTinephrine. As a result of the influences of this 
hormone , a variet y of changes in the resting _hysiology 
of the organism are incurred, which usually aid t he in-
dividua l in meeting the stressful challenge. O" .. e of the 
first changes \vhich is known t o occur i.l;:, a result of 
the a ction of endogenous or exogenous epinephrine is a 
generalized hyperglycemia. Although thi s fund amental 
observati on has been known for half a century, a com-
plete understanding of the mechanism of a ction is still 
lacking . In the fas ting animal, it could l ogica lly 
result f r om an increased liver glyco genolys is and/or a 
de creased glucose uptake by the tissues. A review of 
the literature has shown that whereas all workers are 
agreed on an increased liver glycogeno lysis as a result 
of epinephrine activity, they are far from agreement on 
the latter phase, the glucose upt ake. The results of 
t his study i ndicate that much of the confusion is due 
to a misuse of terms, for it has been demonstrated that, 
at least in vitro , the glucose uptake of muscle tissue 
increases, while the amount of glucos e utilized decreases 
foll owing ep inephrine. The extra glucose is stored i n 
1 
t,he form of' hexo s emonophosphate. 
There have recently been made available a nwnber 
of compounda belonging to the aryl-2-haloalkylamine 
s eries , of which Dibenamine is a type compound , which 
have the ability to i nhibit many of the actions of 
exogenous or endogenous e pinephrine. For this reason, 
they are known as adrenergic blocking drugs. It was of 
interest to study a number of' these compounds to deter-
mine their ab ility to inhibit e pinephrine-induced 
hyperglycemia . A standard intravenous dose of 4 gamlnu/ kg . 
1.-.ra s used as t he cha llenging dose of epinephrine on the 
basis of a dose- response curve and the previous report 
that it was within physiologic range. The f'ollm'fi ng 
compounds were 'cested. They are listed by t he aryl 
portion of' the mo lecules: 2-orthobenzyl phenoxyethyl; 
l-phenyl-2-N-methylbenzyl; 9-fluorenyl; 1-naphthylmethyl; 
methylthionaphthalene; 2-biphenylyloxy; benzhydryl ; and 
one dihydrogenated derivative of ergot, dihydroergocornine . 
It is suggested that the effectiveness of 2-haloalkylami nes 
in dimi nishing or blocking epinephri ne -induced hyperglycemia 
i n rabbits is r oughl y rel<.Jted to their potency as measured 
by antagonism of t he other effects of epinephrine. The 
basi s of' this suggestion is that the most potent drugs 
block or diminish the blood sugar rise i n a dose of' 
2 mg./kg ., while the less potent homologues re quire a 
dose of 5 mg . /kg . t o obtain the same ef:Coct. The leas t 
potent of t he se a~ent s did not reduce the hyperglycemi a 
even in a dose of 10 ms ./kg . In addit ion , the nethyl 
hoiilolo gue of one of the adrener gi c blodcing drugs is 
known tu have a r:urkedly reduced epinephrine antagonism, 
and did not have any effect on the h yperglycemi a . Like-
viise , when the halogen i s repl a ced by an hydroxyl radical, 
and the re::sulting a gent lose s i-cs epinephrine reversal 
action , it al so los es it s ability to blo ck ep inephri ne -
induced hyper glycemia. A reviev·.r of t he literature , to -
gether with the data obtained , se~ 1s to indicate t hat it 
i s a general property of t he aarenergic blocking drugs 
to inhib i t the hypergl ycemic effect of epine~1ri ne in 
t he rabbit. lso, it is to be expe cted tha t l~rger 
doses of blo ck i ng drug are re qui red to inhibit 
epi nephri ne -induced hyperglycemia t han e inephrine-
i nduc ed hypertension . The h ypertens i ve action of 
e l. ine- hri ne is due to an al r_:,ebraic su1maation of a 
pre::ssor and depressor phase . Hence, a sli ght inhi-
bition of t he pressor response be comes magni f ied by the 
depre::ssor a ction . However , in -che glycemic effect of 
epinephrine , only a hypergly c~mic phase is present , and 
woul~ re uire larger doses of blocLing drug -co indu ce 
an equivalent aiminution to that found in -che blood 
pressure response. 
3 
Cert ain of the_ available synthetic antihi s t a -
minic drugs are known to increa se or decrease some of 
the effects of ep inephrine . Nevertheless , they have 
been generally regarded us fairly specific for their 
blo ckin~ action of h istamine . A number of these agents 
were studied to determine their effect on epinephrine-
i ndu ced hyperglycemia in rabbits. The same challengi ng 
dose of 4 gamoa/ kg . injected i ntravenously was used . 
When the antihi stamines 1rrere injected i ntravenously and 
slowly, they did not produce any ri se in the blood sugar 
l evel of fast ing r abbits. The f ollov.Jing compounds have 
be en described as being among the most potent anti-
hist amines when the effects of histamine on bronchioles 
and intestines of guinea p i gs were used as test objects: 
Thenyl pyr amine (Histadyl); Ch lorothen; Pyr anisamine 
( Ne oant:.ergan ); Tripe lenamin e (Pyribenzamine ); Phenergan; 
Chlorprophenpyridamine ( Chlortrimeton); and 1-(10-a cridyl)-
2 - dimethylaminoethane . HCl. These were a l so found to be 
most eff ctive in dimini shi ng epinephrine-induced hyper-
glycemia i n rabbits. It is believed t hat t his a ctivity 
is not due to t he ethylenediamine s t ructure which i s 
present in mos t of these compounds, since two a ctive 
compounds t ested did not have this ;:,tructure . In addition, 
aminophylline was ineffective even v.rhen i n j ected in 
amounts represent ing at least t"llvice as mu ch ethyl enediamine 
4_ 
a;:; contained in un uffoc.ti ve dose of anti histamines 
of the ethylenedi amine type. Fur"'Cheruore , Letho.-
pheneli n e ( Diatrin ) a nd Thonzyl amine ( Neohetrct.ra ine ) 
which do co ntain the ethylenediamine :.:;tructure, did not 
markedly inhibit the h yperglycemia. \ number of other 
compounds were tested •Hh ich have been reported to have 
on l y ueak antihistaminic act ivity, and these agents 
had only a very weak inhibiting act io n . It is unlikel~ 
tha t t h e activity of thGse compounds is related to t heir 
local a nesthetic pr01)erties , sinc e cocaine <Otnd procaine 
d i d n ot i nfluence ep inephrine - induced hyperg lycemi a . 
In addit i on , the find ing that utro pi 1e -vms ineff ective, 
me1k es it unli ke ly that Jche activity is related to the 
atropi11e - lil e a ction of so i1e uf t hese cornpou 1ds . How-
ever it is notev,rort.hy tha t ? itressin, i?ito cin, and 
e ph e d:c ii.le \·Jere all efi"ecti ve in reducing the hyper-
glycemia. 3ince t hese t hree e1gents all p roduce vaso -
constriction and other circulatory c hanges, it suggests 
t hat an i n ter feren ce i:d the di stribution of h yperglycemia 
due to a redistribution of blood, or some other such 
circulatory change influencing cm··bohydrate metabolism 
i ndirectly , may be t he 1 ~. e chanis r:1 of <-1ct ion of so1~1e of 
t h e ant i histamines . 
Epine~Jh:cine w etS infused ilYcraveuously i nt o 
trained , unanesthetized do g s and the effect of Hi:.:;tadyl 
5. 
and Chlortrimeton on the . resulting hyperglycemia and 
lactica cidemia was examined . Interestingly, these 
agents , most potent i n rab its, were without effect in 
dogs; i11deed, they potentiated the maximum rise in blood 
sugar . Chlorothen, however, did significantly reduce 
the hy er glycemia , a lthough none of these agents reduced 
the lacticac idemia. The adrene r gi c bl ocking drugs N- 9-
fluorenyl and 1-phenyl - 2- N- met hyl of the 2-ha loalkyl ami ne 
series were a lso tested in dogs and found to reduce the 
hy~erglycemia, al though they did not influence t he 
l a cti caciderilia. Dihydroergocornine was without effect 
in do gs , but this i s bel i ev ed t o be a dosage effect. 
Finally, the effect of a der ivative of ergo t, 
dihydroergocornine ( DH0 -180 ), a member of the aryl-2-
hal oalkyl ami ne series, N- 9-fluorenyl ( SY-21), and an 
antihist· mi ne , pyranisamine (Neoantergan) V~rere tested 
for t heir ability to influence epi nephrine-induced 
effect s on carbohydrate me tabolism i n vi tro . A standard 
/ 
concentration of 1.6 X 10- o M of !-epinephrine was 
selected a s the cha l lenging dose f or use with the iso-
lated diaphr agm and liver slice of the rat . In the 
mus cle tissue, ep i nephrine was f ound to increase the 
oxygen utilization and the amount of glucose uptake; how-
ever, the amount of glyco gen synthesized and glucose uti-
lized was de creased . In the liver sl ic e , epinephrine c aused 
6 
an increase iri glycog~nolysis and oxyge n utilization. 
SY-21 was found to completely block the infl uence of 
epi nephrine on muscle, v.rhereas it only part i a l l y in-
hibited the effect i n liver tissue. This suggests an 
exp l anat i on for t h e partia l inhibition of t he hyper-
glycemia in rabbits, since only a partia l reduction 
in liver glycogenolysis would only result in a 
partial reduction of t he hyper glycemia. 
Since SY-21 completely inhibited the glycolys i s 
induced by epinephrine i n the isolated r at di aphragm , 
it is suggested that t he f a ilure of this druk to reduce 
the lact ic acidemi a i n the dog was not due to a failure 
t o inhibit glycolysis. SY-21, in the presence of epi-
ne brine causes adro p in blood pressure and pre sumably 
blood flow. Therefore, i t is possible that lact ic acid 
would be a ccumulated in the blood stream , and measurements 
of a given a li quot of b .ood \•mu ld r eveal a high l a ctic 
a c id concent r ation a lthough the rate of musc le glycolysis 
was not elevated. 
Contrary to the effects of SY- 21 , we r e the 
effe cts of DH0- 180 which exhibited only a partial in-
hib ition of the effects in muscle , but a complete i n -
.hibition of the effect s in liver. Hence, it is to be 
expected , as was found, that in vivo this agent would 
produce a complete inhibition of epinephrine-induced 
7. 
hyperglycemia . 
Neoantergan was without activit y when added to 
the surviving rat diaphragm and liver even in high 
concentration. This finding, together with those in 
the intact dog, suggest that the abi lity of the anti-
histamines t o inhibit epinephrine-induced hyperglycemia 
in the r abbit is species specific. 
It is concluded that epinephriue induces its 
hyperglycemic a ction primarily through an increased 
liver glycogenolysis. A general property of the more 
potent adrenergic blocki ng drugs is to inhibit 
epinephrine-induced hyperglycemia in several mammalian 
species . This property exi sts both in vitro and in vivo . 
Their me chanism of a ction i s believed to be a blockade 
of the e ffect of epinephr'ine retther than any direct 
effect on cC1 rb'ohydrate metabolism. 
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